954 results on '"Zorn A."'
Search Results
2. Intrathymic differentiation of natural antibody-producing plasma cells in human neonates
- Author
-
Emmanuel Zorn, Emile A. Bacha, Hector Cordero, Siu-Hong Ho, Alexander M. Chong, Pranay Dogra, Anne-Catrin Uhlemann, David Kalfa, Rodney G. King, Sarah B. See, John F. Kearney, and Chloe Dufeu
- Subjects
Adult ,Science ,Plasma Cells ,Immunoglobulin Variable Region ,General Physics and Astronomy ,Thymus Gland ,Immunoglobulin D ,General Biochemistry, Genetics and Molecular Biology ,Article ,Antigens, CD ,Plasma cell differentiation ,medicine ,Humans ,Lymphopoiesis ,RNA-Seq ,B cell ,B-Lymphocytes ,Principal Component Analysis ,B cells ,Multidisciplinary ,biology ,Gene Expression Profiling ,Infant, Newborn ,Cell Differentiation ,General Chemistry ,T lymphocyte ,Antimicrobial responses ,Fetal Blood ,Immunity, Innate ,Lymphocyte Subsets ,B-1 cell ,Lymphatic system ,medicine.anatomical_structure ,Immunoglobulin G ,Immunology ,biology.protein ,Somatic Hypermutation, Immunoglobulin ,Antibody ,Single-Cell Analysis ,Immunoglobulin Heavy Chains ,Transcriptome - Abstract
The thymus is a central lymphoid organ primarily responsible for the development of T cells. A small proportion of B cells, however, also reside in the thymus to assist negative selection of self-reactive T cells. Here we show that the thymus of human neonates contains a consistent contingent of CD138+ plasma cells, producing all classes and subclasses of immunoglobulins with the exception of IgD. These antibody-secreting cells are part of a larger subset of B cells that share the expression of signature genes defining mouse B1 cells, yet lack the expression of complement receptors CD21 and CD35. Data from single-cell transcriptomic, clonal correspondence and in vitro differentiation assays support the notion of intrathymic CD138+ plasma cell differentiation, alongside other B cell subsets with distinctive molecular phenotypes. Lastly, neonatal thymic plasma cells also include clones reactive to commensal and pathogenic bacteria that commonly infect children born with antibody deficiency. Thus, our findings point to the thymus as a source of innate humoral immunity in human neonates., The thymus is known as the organ of T lymphocyte development. Here authors show that terminal B cell differentiation also takes place in the thymus of human neonates, leading to antibody production against commensal and pathogenic bacteria.
- Published
- 2021
3. Rating the Potential Suitability of Habitat in Michigan Stream Reaches for Arctic Grayling
- Author
-
Nancy A. Auer, Archie W. Martell, Troy G. Zorn, Dan W. Mays, Cameron W. Goble, and J. Marty Holtgren
- Subjects
Fishery ,Ecology ,Habitat ,Arctic ,biology ,Environmental science ,Animal Science and Zoology ,Grayling ,biology.organism_classification ,Ecology, Evolution, Behavior and Systematics ,Nature and Landscape Conservation - Abstract
Present-day environments and anticipated future conditions often pose a significant challenge to efforts to reintroduce extirpated species, highlighting the need for collaborative, thorough approaches to reintroductions. Such is the case in Michigan, where numerous partners are working to reintroduce Arctic Grayling Thymallus arcticus with hopes of reestablishing self-sustaining populations. With > 47,000 km of coldwater stream habitat in the state and limited numbers of eggs for reintroductions, a prioritization framework was needed to provide a standardized, fine-scale method for rating suitability of streams for reintroductions. Through facilitated discussions with stakeholders and experts, we developed an overall prioritization framework for rating Michigan streams with components evaluating a reach's thermal, instream habitat, biological, and connectivity characteristics. Within the context of this broader framework, we developed the habitat rating component for assessing suitability of instream conditions for egg, fry, juvenile, and adult life stages of Arctic Grayling. Life-stage-specific habitat metrics and scoring criteria from this effort were used to rate habitat conditions for 45 reaches in tributaries of Michigan's Manistee River, enabling identification of reaches likely having instream habitat most suitable for Arctic Grayling. Numbers of reaches meeting or exceeding 60%, 70%, and 80% of the maximum score for overall habitat suitability were 31, 8, and 1. Upon completion of the fish assemblage and connectivity components, the prioritization framework and habitat rating process described here will be used for comparing suitability among streams throughout the historical range of Arctic Grayling in Michigan and guiding reintroduction efforts. Though it will take considerable time before instream habitat suitability criteria can be evaluated for all life-stages of Arctic Grayling in Michigan, the collaborative stream prioritization framework developed for Arctic Grayling reintroduction can be readily adapted to reintroduction efforts for other species elsewhere.
- Published
- 2021
- Full Text
- View/download PDF
4. Very low-dose recombinant Factor VIIa administration for cardiac surgical bleeding reduces red blood cell transfusions and renal risk: a matched cohort study
- Author
-
Alice Campton, Jianghua He, Elizabeth Cotter, Brigid C. Flynn, Akshit Sharma, Trip Zorn, Guangyi Gao, and Katy Wirtz
- Subjects
Adult ,Male ,medicine.medical_specialty ,Blood Loss, Surgical ,Factor VIIa ,Young Adult ,Postoperative Complications ,Matched cohort ,Humans ,Medicine ,Renal Insufficiency ,Cardiac Surgical Procedures ,Aged ,Retrospective Studies ,Aged, 80 and over ,Dose-Response Relationship, Drug ,biology ,business.industry ,Incidence (epidemiology) ,Hematology ,General Medicine ,Perioperative ,Middle Aged ,medicine.disease ,Thrombosis ,Recombinant Proteins ,Cardiac surgery ,Red blood cell ,medicine.anatomical_structure ,Recombinant factor VIIa ,Anesthesia ,Cohort ,biology.protein ,Female ,Erythrocyte Transfusion ,business - Abstract
Outcomes following administration of very-low-dose recombinant activated factor VIIa (vld-rFVIIa) for cardiac surgical bleeding remain debatable. We sought to determine the association of vld-rFVIIa and adverse surgical outcomes. Retrospective, cohort matching of patients undergoing cardiac surgery who received vld-rFVIIa (median 13.02 μg/kg) for perioperative bleeding were matched to cardiac surgical patients who had bleeding and received standard of care for bleeding without Factor VIIa administration. Of the 362 matched patients (182 in each group), patients who received rFVIIa required significantly less red blood cell transfusions [median 3 units (range 0--60, IQR = 4 units) versus 4 units (range 2-34, IQR = 4 units); P = 0.0004], decreased length of hospital stay (median 8 versus 9 days; P = 0.0158) and decreased renal risk (P
- Published
- 2021
- Full Text
- View/download PDF
5. Diet and trophic ecology of introduced salmonines at two south shore ports of Lake Superior, 2019
- Author
-
Shawn P. Sitar, Brandon S. Gerig, Benjamin R. Vasquez, John A. Whitinger, and Troy G. Zorn
- Subjects
0106 biological sciences ,Ecology ,biology ,Splake ,010604 marine biology & hydrobiology ,Pelagic zone ,010501 environmental sciences ,Aquatic Science ,biology.organism_classification ,01 natural sciences ,Rainbow smelt ,Oncorhynchus ,Salmo ,Ecology, Evolution, Behavior and Systematics ,0105 earth and related environmental sciences ,Trophic level ,Isotope analysis ,Salvelinus - Abstract
Introduced salmonines (Oncorhynchus spp. and Salmo spp.) are important components of recreational fisheries in the Great Lakes. These fishes were stocked heavily following the fishery collapse of lake trout (Salvelinus namaycush) due to sea lamprey (Petromyzon marinus) predation and commercial overharvest. While salmonine introductions occurred in all five of the Great Lakes, Lake Superior is less productive than the lower Great Lakes restricting most introduced salmonines to a small percentage of available habitat. This suggests the potential for high resource overlap between salmonines, yet little information has been published related to the trophic ecology of introduced salmonines in Lake Superior. Furthermore, hybrid splake (S. namaycush × S. fontinalis) are also stocked by various state agencies while little information on their trophic ecology exists. To address uncertainties associated with introduced salmonines, we assessed the diet composition and isotopic niche overlap of fish collected from two south shore ports of Lake Superior. Introduced salmonines consumed similar prey items including rainbow smelt (Osmerus mordax), coregonines, and three-spined stickleback (Gasterosteus aculeatus) in varying amounts, with a notable percentage of diet comprising terrestrial invertebrates. These results are further supported by stable isotope analysis which indicated high isotopic niche overlap among introduced salmonines suggesting a mixed diet attributed to benthic, pelagic, and terrestrial sources. Our characterization of the salmonine community provides important information that will inform fisheries research and management in Lake Superior.
- Published
- 2021
- Full Text
- View/download PDF
6. A multicriteria decision analysis comparing pharmacotherapy for chronic neuropathic pain, including cannabinoids and cannabis-based medical products
- Author
-
Anne Katrin Schlag, Haggai Sharon, Julie Moltke, David P. Finn, Gregor Zorn, David J. Nutt, Tina Horsted, Alan Fayaz, Chloe Sakal, Brigitta Brander, Helen Valerie Curran, Lawrence D. Phillips, Michael P. Barnes, Saoirse E. O'Sullivan, and Timothy Williams
- Subjects
Adult ,medicine.medical_specialty ,Decision Support Techniques ,chemistry.chemical_compound ,medicine ,Duloxetine ,Cannabidiol ,Humans ,Pharmacology (medical) ,Dronabinol ,Intensive care medicine ,Cannabis ,Pharmacology ,Cannabinoid Receptor Agonists ,Analgesics ,biology ,business.industry ,Cannabinoids ,Chronic pain ,biology.organism_classification ,medicine.disease ,RM Therapeutics. Pharmacology ,Clinical trial ,Complementary and alternative medicine ,chemistry ,Neuropathic pain ,Hallucinogens ,Quality of Life ,RA Public aspects of medicine ,Neuralgia ,business ,Oxycodone ,Methadone ,medicine.drug - Abstract
Background: Pharmacological management of chronic neuropathic pain (CNP) still represents a major clinical challenge. Collective harnessing of both the scientific evidence base and clinical experience (of clinicians and patients) can play a key role in informing treatment pathways and contribute to the debate on specific treatments (e.g., cannabinoids). A group of expert clinicians (pain specialists and psychiatrists), scientists, and patient representatives convened to assess the relative benefit-safety balance of 12 pharmacological treatments, including orally administered cannabinoids/cannabis-based medicinal products, for the treatment of CNP in adults. Methods: A decision conference provided the process of creating a multicriteria decision analysis (MCDA) model, in which the group collectively scored the drugs on 17 effect criteria relevant to benefits and safety and then weighted the criteria for their clinical relevance. Findings: Cannabis-based medicinal products consisting of tetrahydrocannabinol/cannabidiol (THC/CBD), in a 1:1 ratio, achieved the highest overall score, 79 (out of 100), followed by CBD dominant at 75, then THC dominant at 72. Duloxetine and the gabapentinoids scored in the 60s, amitriptyline, tramadol, and ibuprofen in the 50s, methadone and oxycodone in the 40s, and morphine and fentanyl in the 30s. Sensitivity analyses showed that even if the pain reduction and quality-of-life scores for THC/CBD and THC are halved, their benefit-safety balances remain better than those of the noncannabinoid drugs. Interpretation: The benefit-safety profiles for cannabinoids were higher than for other commonly used medications for CNP largely because they contribute more to quality of life and have a more favorable side effect profile. The results also reflect the shortcomings of alternative pharmacological treatments with respect to safety and mitigation of neuropathic pain symptoms. Further high-quality clinical trials and systematic comprehensive capture of clinical experience with cannabinoids is warranted. These results demonstrate once again the complexity and multimodal mechanisms underlying the clinical experience and impact of chronic pain.
- Published
- 2022
7. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
- Author
-
Coignard, Juliette, Lush, Michael, Beesley, Jonathan, O’Mara, Tracy A., Dennis, Joe, Tyrer, Jonathan P., Barnes, Daniel R., McGuffog, Lesley, Leslie, Goska, Bolla, Manjeet K., Adank, Muriel A., Agata, Simona, Ahearn, Thomas, Aittomäki, Kristiina, Andrulis, Irene L., Anton-Culver, Hoda, Arndt, Volker, Arnold, Norbert, Aronson, Kristan J., Arun, Banu K., Augustinsson, Annelie, Azzollini, Jacopo, Barrowdale, Daniel, Baynes, Caroline, Becher, Heko, Bermisheva, Marina, Bernstein, Leslie, Białkowska, Katarzyna, Blomqvist, Carl, Bojesen, Stig E., Bonanni, Bernardo, Borg, Ake, Brauch, Hiltrud, Brenner, Hermann, Burwinkel, Barbara, Buys, Saundra S., Caldés, Trinidad, Caligo, Maria A., Campa, Daniele, Carter, Brian D., Castelao, Jose E., Chang-Claude, Jenny, Chanock, Stephen J., Chung, Wendy K., Claes, Kathleen B. M., Clarke, Christine L., Bertrand, Ophélie, Caputo, Sandrine, Dupré, Anaïs, le Mentec, Marine, Belotti, Muriel, Birot, Anne-Marie, Buecher, Bruno, Fourme, Emmanuelle, Gauthier-Villars, Marion, Golmard, Lisa, Houdayer, Claude, Moncoutier, Virginie, de Pauw, Antoine, Saule, Claire, Sinilnikova, Olga, Mazoyer, Sylvie, Damiola, Francesca, Barjhoux, Laure, Verny-Pierre, Carole, Léone, M. lanie, Boutry-Kryza, Nadia, Calender, Alain, Giraud, Sophie, Caron, Olivier, Guillaud-Bataille, Marine, Bressac-de-Paillerets, Brigitte, Bignon, Yves- Jean, Uhrhammer, Nancy, Lasset, Christine, Bonadona, Valérie, Berthet, Pascaline, Vaur, Dominique, Castera, Laurent, Noguchi, Tetsuro, Popovici, Cornel, Sobol, Hagay, Bourdon, Violaine, Remenieras, Audrey, Noguès, Catherine, Coupier, Isabelle, Pujol, Pascal, Dumont, Aurélie, Révillion, Françoise, Adenis, Claude, Muller, Danièle, Barouk-Simonet, Emmanuelle, Bonnet, Françoise, Bubien, Virginie, Sevenet, Nicolas, Longy, Michel, Toulas, Christine, Guimbaud, Rosine, Gladieff, Laurence, Feillel, Viviane, Leroux, Dominique, Dreyfus, H. lène, Rebischung, Christine, Peysselon, Magalie, Coron, Fanny, Faivre, Laurence, Baurand, Amandine, Jacquot, Caroline, Bertolone, Geoffrey, Lizard, Sarab, Prieur, Fabienne, Lebrun, Marine, Kientz, Caroline, Ferrer, Sandra Fert, Mari, V. ronique, Vénat-Bouvet, Laurence, Delnatte, Capucine, Bézieau, Stéphane, Mortemousque, Isabelle, Coulet, Florence, Colas, Chrystelle, Soubrier, Florent, Warcoin, Mathilde, Sokolowska, Johanna, Bronner, Myriam, Collonge-Rame, Marie-Agnès, Damette, Alexandre, Gesta, Paul, Lallaoui, Hakima, Chiesa, Jean, Molina-Gomes, Denise, Ingster, Olivier, Gregory, Helen, Miedzybrodzka, Zosia, Morrison, Patrick J., Ong, Kai-ren, Donaldson, Alan, Rogers, Mark T., Kennedy, M. John, Porteous, Mary E., Brewer, Carole, Davidson, Rosemarie, Izatt, Louise, Brady, Angela, Barwell, Julian, Adlard, Julian, Foo, Claire, Lalloo, Fiona, Side, Lucy E., Eason, Jacqueline, Henderson, Alex, Walker, Lisa, Eeles, Rosalind A., Cook, Jackie, Snape, Katie, Eccles, Diana, Murray, Alex, McCann, Emma, Collée, J. Margriet, Conroy, Don M., Czene, Kamila, Daly, Mary B., Devilee, Peter, Diez, Orland, Ding, Yuan Chun, Domchek, Susan M., Dörk, Thilo, dos-Santos-Silva, Isabel, Dunning, Alison M., Dwek, Miriam, Eccles, Diana M., Eliassen, A. Heather, Engel, Christoph, Eriksson, Mikael, Evans, D. Gareth, Fasching, Peter A., Flyger, Henrik, Fostira, Florentia, Friedman, Eitan, Fritschi, Lin, Frost, Debra, Gago-Dominguez, Manuela, Gapstur, Susan M., Garber, Judy, Garcia-Barberan, Vanesa, García-Closas, Montserrat, García-Sáenz, José A., Gaudet, Mia M., Gayther, Simon A., Gehrig, Andrea, Georgoulias, Vassilios, Giles, Graham G., Godwin, Andrew K., Goldberg, Mark S., Goldgar, David E., González-Neira, Anna, Greene, Mark H., Guénel, Pascal, Haeberle, Lothar, Hahnen, Eric, Haiman, Christopher A., Håkansson, Niclas, Hall, Per, Hamann, Ute, Harrington, Patricia A., Hart, Steven N., He, Wei, Hogervorst, Frans B. L., Hollestelle, Antoinette, Hopper, John L., Horcasitas, Darling J., Hulick, Peter J., Hunter, David J., Imyanitov, Evgeny N., Fox, Stephen, Campbell, Ian, Spurdle, Amanda, Webb, Penny, de Fazio, Anna, Tassell, Margaret, Kirk, Judy, Lindeman, Geoff, Price, Melanie, Southey, Melissa, Milne, Roger, Deb, Sid, Bowtell, David, van der Hout, Annemieke H., van den Ouweland, Ans M. W., Mensenkamp, Arjen R., van Deurzen, Carolien H. M., Kets, Carolien M., Seynaeve, Caroline, van Asperen, Christi J., Aalfs, Cora M., Gómez Garcia, Encarna B., van Leeuwen, Flora E., de Bock, G. H., Meijers-Heijboer, Hanne E. J., Obdeijn, Inge M., Gille, J. J. P., Oosterwijk, Jan C., Wijnen, Juul T., van der Kolk, Lizet E., Hooning, Maartje J., Ausems, Margreet G. E. M., Mourits, Marian J. E., Blok, Marinus J., Rookus, Matti A., van der Luijt, Rob B., van Cronenburg, T. C. T. E. F., van der Pol, Carmen C., Russell, Nicola S., Siesling, Sabine, Overbeek, Lucy, Wijnands, R., de Lange, Judith L., Clarke, Christine, Graham, Dinny, Sachchithananthan, Mythily, Marsh, Deborah, Scott, Rodney, Baxter, Robert, Yip, Desmond, Carpenter, Jane, Davis, Alison, Pathmanathan, Nirmala, Simpson, Peter, Jager, Agnes, Jakubowska, Anna, James, Paul A., Jensen, Uffe Birk, John, Esther M., Jones, Michael E., Kaaks, Rudolf, Kapoor, Pooja Middha, Karlan, Beth Y., Keeman, Renske, Khusnutdinova, Elza, Kiiski, Johanna I., Ko, Yon-Dschun, Kosma, Veli-Matti, Kraft, Peter, Kurian, Allison W., Laitman, Yael, Lambrechts, Diether, le Marchand, Loic, Lester, Jenny, Lesueur, Fabienne, Lindstrom, Tricia, Lopez-Fernández, Adria, Loud, Jennifer T., Luccarini, Craig, Mannermaa, Arto, Manoukian, Siranoush, Margolin, Sara, Martens, John W. M., Mebirouk, Noura, Meindl, Alfons, Miller, Austin, Milne, Roger L., Montagna, Marco, Nathanson, Katherine L., Neuhausen, Susan L., Nevanlinna, Heli, Nielsen, Finn C., O’Brien, Katie M., Olopade, Olufunmilayo I., Olson, Janet E., Olsson, H. kan, Osorio, Ana, Ottini, Laura, Park-Simon, Tjoung-Won, Parsons, Michael T., Pedersen, Inge Sokilde, Peshkin, Beth, Peterlongo, Paolo, Peto, Julian, Pharoah, Paul D. P., Phillips, Kelly-Anne, Polley, Eric C., Poppe, Bruce, Presneau, Nadege, Pujana, Miquel Angel, Punie, Kevin, Radice, Paolo, Rantala, Johanna, Rashid, Muhammad U., Rennert, Gad, Rennert, Hedy S., Robson, Mark, Romero, Atocha, Rossing, Maria, Saloustros, Emmanouil, Sandler, Dale P., Santella, Regina, Scheuner, Maren T., Schmidt, Marjanka K., Schmidt, Gunnar, Scott, Christopher, Sharma, Priyanka, Soucy, Penny, Southey, Melissa C., Spinelli, John J., Steinsnyder, Zoe, Stone, Jennifer, Stoppa-Lyonnet, Dominique, Swerdlow, Anthony, Tamimi, Rulla M., Tapper, William J., Taylor, Jack A., Terry, Mary Beth, Teulé, Alex, Thull, Darcy L., Tischkowitz, Marc, Toland, Amanda E., Torres, Diana, Trainer, Alison H., Truong, Thérèse, Tung, Nadine, Vachon, Celine M., Vega, Ana, Vijai, Joseph, Wang, Qin, Wappenschmidt, Barbara, Weinberg, Clarice R., Weitzel, Jeffrey N., Wendt, Camilla, Wolk, Alicja, Yadav, Siddhartha, Yang, Xiaohong R., Yannoukakos, Drakoulis, Zheng, Wei, Ziogas, Argyrios, Zorn, Kristin K., Park, Sue K., Thomassen, Mads, Offit, Kenneth, Schmutzler, Rita K., Couch, Fergus J., Simard, Jacques, Chenevix-Trench, Georgia, Easton, Douglas F., Andrieu, Nadine, Antoniou, Antonis C., German Cancer Research Center, National Health and Medical Research Council (Australia), United States of Department of Health & Human Services, National Institute for Health Research (Reino Unido), French National Cancer Institute, Ligue Nationale Contre le Cancer (Francia), Cancer Research UK (Reino Unido), Unión Europea. Comisión Europea, Canadian Institutes of Health Research, Cancer Council New South Wales (Australia), KWF Kankerbestrijding, Instituto de Salud Carlos III, Xunta de Galicia (España), Ministerio de Sanidad, Política Social e Igualdad (España), Helmholtz Association, California Breast Cancer Research Program, Federal Ministry of Education & Research (Alemania), Government of Netherlands, Russian Foundation for Basic Research, O’Mara, Tracy A. [0000-0002-5436-3232], Dennis, Joe [0000-0003-4591-1214], Tyrer, Jonathan P. [0000-0003-3724-4757], Barnes, Daniel R. [0000-0002-3781-7570], Leslie, Goska [0000-0001-5756-6222], Ahearn, Thomas [0000-0003-0771-7752], Andrulis, Irene L. [0000-0002-4226-6435], Arndt, Volker [0000-0001-9320-8684], Azzollini, Jacopo [0000-0002-9364-9778], Barrowdale, Daniel [0000-0003-1661-3939], Becher, Heko [0000-0002-8808-6667], Bernstein, Leslie [0000-0002-7692-6518], Bojesen, Stig E. [0000-0002-4061-4133], Bonanni, Bernardo [0000-0003-3589-2128], Brauch, Hiltrud [0000-0001-7531-2736], Caldés, Trinidad [0000-0002-1038-5392], Chanock, Stephen J. [0000-0002-2324-3393], Chung, Wendy K. [0000-0003-3438-5685], Claes, Kathleen B. M. [0000-0003-0841-7372], Collée, J. Margriet [0000-0002-9272-9346], Devilee, Peter [0000-0002-8023-2009], Dörk, Thilo [0000-0002-9458-0282], Dunning, Alison M. [0000-0001-6651-7166], Dwek, Miriam [0000-0001-7184-2932], Eliassen, A. Heather [0000-0002-3961-6609], Fritschi, Lin [0000-0002-7692-3560], García-Closas, Montserrat [0000-0003-1033-2650], García-Sáenz, José A. [0000-0001-6880-0301], Gayther, Simon A. [0000-0001-7937-5443], Giles, Graham G. [0000-0003-4946-9099], Greene, Mark H. [0000-0003-1852-9239], Guénel, Pascal [0000-0002-8359-518X], Håkansson, Niclas [0000-0001-7673-5554], Hart, Steven N. [0000-0001-7714-2734], He, Wei [0000-0003-0161-3274], Hollestelle, Antoinette [0000-0003-1166-1966], Hulick, Peter J. [0000-0001-8397-4078], Jakubowska, Anna [0000-0002-5650-0501], James, Paul A. [0000-0002-4361-4657], Jensen, Uffe Birk [0000-0002-6205-6355], Jones, Michael E. [0000-0001-7479-3451], Kapoor, Pooja Middha [0000-0001-5503-8215], Keeman, Renske [0000-0002-5452-9933], Kraft, Peter [0000-0002-4472-8103], Kurian, Allison W. [0000-0002-6175-9470], Lambrechts, Diether [0000-0002-3429-302X], Lesueur, Fabienne [0000-0001-7404-4549], Martens, John W. M. [0000-0002-3428-3366], Miller, Austin [0000-0001-9739-8462], Milne, Roger L. [0000-0001-5764-7268], Nathanson, Katherine L. [0000-0002-6740-0901], Nevanlinna, Heli [0000-0002-0916-2976], Olopade, Olufunmilayo I. [0000-0002-9936-1599], Olson, Janet E. [0000-0003-4944-7789], Ottini, Laura [0000-0001-8030-0449], Parsons, Michael T. [0000-0003-3242-8477], Pedersen, Inge Sokilde [0000-0002-9902-8040], Peshkin, Beth [0000-0002-2997-4701], Peterlongo, Paolo [0000-0001-6951-6855], Peto, Julian [0000-0002-1685-8912], Pharoah, Paul D. P. [0000-0001-8494-732X], Punie, Kevin [0000-0002-1162-7963], Radice, Paolo [0000-0001-6298-4111], Rennert, Gad [0000-0002-8512-068X], Robson, Mark [0000-0002-3109-1692], Romero, Atocha [0000-0002-1634-7397], Saloustros, Emmanouil [0000-0002-0485-0120], Sandler, Dale P. [0000-0002-6776-0018], Schmidt, Marjanka K. [0000-0002-2228-429X], Scott, Christopher [0000-0003-1340-0647], Stone, Jennifer [0000-0001-5077-0124], Toland, Amanda E. [0000-0002-0271-1792], Truong, Thérèse [0000-0002-2943-6786], Vachon, Celine M. [0000-0002-1962-9322], Vega, Ana [0000-0002-7416-5137], Vijai, Joseph [0000-0002-7933-151X], Weitzel, Jeffrey N. [0000-0001-6714-092X], Wolk, Alicja [0000-0001-7387-6845], Yadav, Siddhartha [0000-0003-4630-9903], Yannoukakos, Drakoulis [0000-0001-7509-3510], Ziogas, Argyrios [0000-0003-4529-3727], Zorn, Kristin K. [0000-0003-2143-8979], Park, Sue K. [0000-0001-5002-9707], Simard, Jacques [0000-0001-6906-3390], Easton, Douglas F. [0000-0003-2444-3247], Apollo - University of Cambridge Repository, Becher, Heiko [0000-0002-8808-6667], RS: GROW - R4 - Reproductive and Perinatal Medicine, MUMC+: DA KG Polikliniek (9), Klinische Genetica, German Cancer Research Center (DKFZ), National Health and Medical Research Council of Australia, United States Department of Health & Human Services National Institutes of Health (NIH) - USA, National Institute for Health Research (NIHR), Institut National du Cancer (INCA) France, Ligue nationale contre le cancer, Cancer Research UK, European Commision, Canadian Institutes of Health Research (CIHR), Cancer Council New South Wales, Accion Estrategica de Salud del Instituto de Salud Carlos III FIS Intrasalud, Xunta de Galicia, Fomento de la Investigacion Clinica Independiente, Ministerio de Sanidad, Servicios Sociales e Igualdad, Spain, Fondo de Investigacion Sanitario, California Breast Cancer Research Fund, Federal Ministry of Education & Research (BMBF), Netherlands Government, Russian Foundation for Basic Research (RFBR), O'Mara, Tracy A [0000-0002-5436-3232], Tyrer, Jonathan P [0000-0003-3724-4757], Barnes, Daniel R [0000-0002-3781-7570], Andrulis, Irene L [0000-0002-4226-6435], Bojesen, Stig E [0000-0002-4061-4133], Chanock, Stephen J [0000-0002-2324-3393], Chung, Wendy K [0000-0003-3438-5685], Claes, Kathleen BM [0000-0003-0841-7372], Collée, J Margriet [0000-0002-9272-9346], Dunning, Alison M [0000-0001-6651-7166], Eliassen, A Heather [0000-0002-3961-6609], García-Sáenz, José A [0000-0001-6880-0301], Gayther, Simon A [0000-0001-7937-5443], Giles, Graham G [0000-0003-4946-9099], Greene, Mark H [0000-0003-1852-9239], Hart, Steven N [0000-0001-7714-2734], Hulick, Peter J [0000-0001-8397-4078], James, Paul A [0000-0002-4361-4657], Jones, Michael E [0000-0001-7479-3451], Kurian, Allison W [0000-0002-6175-9470], Martens, John WM [0000-0002-3428-3366], Milne, Roger L [0000-0001-5764-7268], Nathanson, Katherine L [0000-0002-6740-0901], Olopade, Olufunmilayo I [0000-0002-9936-1599], Olson, Janet E [0000-0003-4944-7789], Parsons, Michael T [0000-0003-3242-8477], Pharoah, Paul DP [0000-0001-8494-732X], Sandler, Dale P [0000-0002-6776-0018], Schmidt, Marjanka K [0000-0002-2228-429X], Toland, Amanda E [0000-0002-0271-1792], Vachon, Celine M [0000-0002-1962-9322], Weitzel, Jeffrey N [0000-0001-6714-092X], Zorn, Kristin K [0000-0003-2143-8979], Park, Sue K [0000-0001-5002-9707], Easton, Douglas F [0000-0003-2444-3247], HUS Comprehensive Cancer Center, Department of Oncology, Clinicum, INDIVIDRUG - Individualized Drug Therapy, HUS Gynecology and Obstetrics, Department of Obstetrics and Gynecology, Institut Català de la Salut, [Coignard J] Genetic Epidemiology of Cancer team, Inserm, U900, Paris, France. Institut Curie Paris, Paris, France. Mines ParisTech Fontainebleau, Paris, France. Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. PSL University Paris, Paris, France. Paris Sud University, Orsay, France. [Lush M, Dennis J] Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. [Beesley J, O'Mara TA] Department of Genetics and Computational Biology QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia. [Tyrer JP] Centre for Cancer Genetic Epidemiology, Department of Oncology University of Cambridge, Cambridge, UK. [Diez O] Oncogenetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Àrea de Genètica Clínica i Molecular, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Lopez-Fernández A] High Risk and Cancer Prevention Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Life Course Epidemiology (LCE), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON), Human Genetics, ARD - Amsterdam Reproduction and Development, Human genetics, Amsterdam Neuroscience - Complex Trait Genetics, CCA - Cancer biology and immunology, Clinical Genetics, Medical Oncology, Pathology, and Radiology & Nuclear Medicine
- Subjects
0301 basic medicine ,Linkage disequilibrium ,endocrine system diseases ,Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES] ,45/43 ,General Physics and Astronomy ,Genome-wide association study ,Linkage Disequilibrium ,Breast cancer ,0302 clinical medicine ,3123 Gynaecology and paediatrics ,Risk Factors ,Genotype ,breast neoplasms ,Medicine and Health Sciences ,631/208/68 ,skin and connective tissue diseases ,Cancer genetics ,adult ,alleles ,BRCA1 protein ,BRCA2 protein ,female ,genetic predisposition to disease ,genome-wide association study ,genotype ,humans ,linkage disequilibrium ,middle aged ,mutation ,quantitative trait loci ,risk factors ,polymorphism, single nucleotide ,HEBON Investigators ,Genetics ,neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES] ,education.field_of_study ,Women's cancers Radboud Institute for Molecular Life Sciences [Radboudumc 17] ,Multidisciplinary ,Otros calificadores::Otros calificadores::/genética [Otros calificadores] ,BRCA1 Protein ,Genetic Predisposition to Disease/genetics ,article ,Single Nucleotide ,Middle Aged ,BRCA2 Protein/genetics ,3. Good health ,Mama - Càncer - Factors de risc ,030220 oncology & carcinogenesis ,Mutation (genetic algorithm) ,Genome-Wide Association Study/methods ,Medical genetics ,Female ,Medical Genetics ,692/499 ,Adult ,medicine.medical_specialty ,45/61 ,Science ,3122 Cancers ,Population ,Quantitative Trait Loci ,Genetic Phenomena::Genetic Variation::Mutation [PHENOMENA AND PROCESSES] ,ABCTB Investigators ,631/67/2324 ,Breast Neoplasms ,Biology ,Breast Neoplasms/genetics ,Polymorphism, Single Nucleotide ,General Biochemistry, Genetics and Molecular Biology ,Càncer de mama ,GEMO Study Collaborators ,03 medical and health sciences ,Cancer epidemiology ,SDG 3 - Good Health and Well-being ,Other subheadings::Other subheadings::/genetics [Other subheadings] ,medicine ,Humans ,Genetic Predisposition to Disease ,Allele ,Polymorphism ,education ,EMBRACE Collaborators ,fenómenos genéticos::variación genética::mutación [FENÓMENOS Y PROCESOS] ,Alleles ,Medicinsk genetik ,BRCA2 Protein ,Mutació (Biologia) ,General Chemistry ,631/67/1347 ,Genotype frequency ,030104 developmental biology ,Mutation ,Mama - Càncer - Aspectes genètics ,BRCA1 Protein/genetics ,3111 Biomedicine ,KConFab Investigators ,Quantitative Trait Loci/genetics ,Genètica ,Genome-Wide Association Study - Abstract
Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants have been shown to modify BC risk for mutation carriers. All but three, were identified in general population studies. Other mutation carrier-specific susceptibility variants may exist but studies of mutation carriers have so far been underpowered. We conduct a novel case-only genome-wide association study comparing genotype frequencies between 60,212 general population BC cases and 13,007 cases with BRCA1 or BRCA2 mutations. We identify robust novel associations for 2 variants with BC for BRCA1 and 3 for BRCA2 mutation carriers, P, Breast cancer risk for BRCA1/BRCA2 mutation carriers varies depending on other genetic factors. Here, the authors perform a case-only genome-wide association study and highlight novel loci associated with breast cancer risk for BRCA1/BRCA2 mutation carriers.
- Published
- 2021
- Full Text
- View/download PDF
8. Cationic Compounds with SARS-CoV-2 Antiviral Activity and Their Interaction with Organic Cation Transporter/Multidrug and Toxin Extruder Secretory Transporters
- Author
-
Xiaohong Zhang, Sean Ekins, Kimberley M. Zorn, Stephen H. Wright, and Lucy J. Martinez-Guerrero
- Subjects
Organic Cation Transport Proteins ,Cetylpyridinium ,CHO Cells ,Tilorone ,Antiviral Agents ,Cricetulus ,Cricetinae ,medicine ,Animals ,Secretion ,Naphthyridines ,IC50 ,Secretory pathway ,Pharmacology ,Organic cation transport proteins ,biology ,SARS-CoV-2 ,Chemistry ,Chinese hamster ovary cell ,Chloroquine ,Transporter ,In vitro ,Metabolism, Transport, and Pharmacogenetics ,Biochemistry ,Quinacrine ,biology.protein ,Molecular Medicine ,Benzalkonium Compounds ,medicine.drug - Abstract
In the wake of the COVID-19 pandemic, drug repurposing has been highlighted for rapid introduction of therapeutics. Proposed drugs with activity against SARS-CoV-2 include compounds with positive charges at physiologic pH, making them potential targets for the organic cation secretory transporters of kidney and liver, i.e., the basolateral organic cation transporters, OCT1 and OCT2; and the apical multidrug and toxin extruders, MATE1 and MATE2-K. We selected several compounds proposed to have in vitro activity against SARS-CoV-2 (chloroquine, hydroxychloroquine, quinacrine, tilorone, pyronaridine, cetylpyridinium, and miramistin) to test their interaction with OCT and MATE transporters. We used Bayesian machine learning models to generate predictions for each molecule with each transporter and also experimentally determined IC(50) values for each compound against labeled substrate transport into CHO cells that stably expressed OCT2, MATE1, or MATE2-K using three structurally distinct substrates (atenolol, metformin and 1-methyl-4-phenylpyridinium) to assess the impact of substrate structure on inhibitory efficacy. For the OCTs substrate identity influenced IC(50) values, although the effect was larger and more systematic for OCT2. In contrast, inhibition of MATE1-mediated transport was largely insensitive to substrate identity. Unlike MATE1, inhibition of MATE2-K was influenced, albeit modestly, by substrate identity. Maximum unbound plasma concentration/IC(50) ratios were used to identify potential clinical DDI recommendations; all the compounds interacted with the OCT/MATE secretory pathway, most with sufficient avidity to represent potential DDI issues for secretion of cationic drugs. This should be considered when proposing cationic agents as repurposed antivirals. SIGNIFICANCE STATEMENT: Drugs proposed as potential COVID-19 therapeutics based on in vitro activity data against SARS-CoV-2 include compounds with positive charges at physiological pH, making them potential interactors with the OCT/MATE renal secretory pathway. We tested seven such molecules as inhibitors of OCT1/2 and MATE1/2-K. All the compounds blocked transport activity regardless of substrate used to monitor activity. Suggesting that plasma concentrations achieved by normal clinical application of the test agents could be expected to influence the pharmacokinetics of selected cationic drugs.
- Published
- 2021
- Full Text
- View/download PDF
9. Formation of Diastereomeric Dihydromenthofurolactones by Cystostereum murrayi and Aroma Dilution Analysis Based on Dynamic Headspace Extraction
- Author
-
Heike Hausmann, Raffael C. Wende, Fabio F. Brescia, Suzan Yalman, Marco A. Fraatz, Wassilios Pitelas, Flavius Popa, and Holger Zorn
- Subjects
0106 biological sciences ,chemistry.chemical_classification ,Chromatography ,biology ,Chemistry ,010401 analytical chemistry ,Diastereomer ,Ether ,General Chemistry ,Nuclear magnetic resonance spectroscopy ,biology.organism_classification ,01 natural sciences ,Terpenoid ,0104 chemical sciences ,Dilution ,chemistry.chemical_compound ,General Agricultural and Biological Sciences ,Aroma ,Flavor ,Lactone ,010606 plant biology & botany - Abstract
Submerged cultures of the basidiomycota Cystostereum murrayi emit an intensive coconut-like, sweetish, and buttery smell. For identification of the key aroma compounds, an aroma dilution analysis using dynamic headspace was performed by adjusting the split ratio of the GC inlet system. Flavor dilution (FD) factors varied from 22 up to ≥218, whereby the largest class of compounds represented terpenoids, including two rare stereoisomers of 3,6-dimethyl-2,3,3a,4,5,7a-hexahydrobenzofuran (dill ether, ee ≥ 99.9). By means of nuclear magnetic resonance spectroscopy, the substances with the highest FD factors (29, 212, and 218) were identified as diastereomers of 3,6-dimethyl-3a,4,5,6,7,7a-hexayhydro-3H-1-benzofuran-2-one (dihydromenthofurolactone) and as its corresponding C3-unsaturated lactone. The latter two compounds have not been described for Cystostereum murrayi or for any other basidiomycota previously. Supplementation studies using 2-13C-d-glucose indicated that these lactones as well as the two stereoisomers of dill ether and other terpenoids were formed de novo by the fungus.
- Published
- 2021
- Full Text
- View/download PDF
10. Multiple Computational Approaches for Predicting Drug Interactions with Human Equilibrative Nucleoside Transporter 1
- Author
-
Kimberley M. Zorn, Nathan J. Cherrington, Sean Ekins, Stephen H. Wright, Thomas R. Lane, and Siennah R. Miller
- Subjects
Drug ,media_common.quotation_subject ,Pharmaceutical Science ,Pharmacology ,Equilibrative nucleoside transporter 1 ,Equilibrative Nucleoside Transporter 1 ,Thioinosine ,Ribavirin ,medicine ,Humans ,Drug Interactions ,Darunavir ,media_common ,Mizoribine ,biology ,Chemistry ,Drug discovery ,Nucleosides ,Transporter ,Articles ,biology.protein ,Ribonucleosides ,Pharmacophore ,Nucleoside ,HeLa Cells ,medicine.drug - Abstract
Equilibrativenucleoside transporters (ENTs) participate in the pharmacokinetics and disposition of nucleoside analog drugs. Understanding drug interactions with the ENTs may inform and facilitate the development of new drugs, including chemotherapeutics and antivirals that require access to sanctuary sites such as the male genital tract. This study created three-dimensional pharmacophores for ENT1 and ENT2 substrates and inhibitors using K(t) and IC(50) data curated from the literature. Substrate pharmacophores for ENT1 and ENT2 are distinct, with partial overlap of hydrogen bond donors, whereas the inhibitor pharmacophores predominantly feature hydrogen bond acceptors. Mizoribine and ribavirin mapped to the ENT1 substrate pharmacophore and proved to be substrates of the ENTs. The presence of the ENT-specific inhibitor 6-S-[(4-nitrophenyl)methyl]-6-thioinosine (NBMPR) decreased mizoribine accumulation in ENT1 and ENT2 cells (ENT1, ∼70% decrease, P = 0.0046; ENT2, ∼50% decrease, P = 0.0012). NBMPR also decreased ribavirin accumulation in ENT1 and ENT2 cells (ENT1: ∼50% decrease, P = 0.0498; ENT2: ∼30% decrease, P = 0.0125). Darunavir mapped to the ENT1 inhibitor pharmacophore and NBMPR did not significantly influence darunavir accumulation in either ENT1 or ENT2 cells (ENT1: P = 0.28; ENT2: P = 0.53), indicating that darunavir’s interaction with the ENTs is limited to inhibition. These computational and in vitro models can inform compound selection in the drug discovery and development process, thereby reducing time and expense of identification and optimization of ENT-interacting compounds. SIGNIFICANCE STATEMENT: This study developed computational models of human equilibrative nucleoside transporters (ENTs) to predict drug interactions and validated these models with two compounds in vitro. Identification and prediction of ENT1 and ENT2 substrates allows for the determination of drugs that can penetrate tissues expressing these transporters.
- Published
- 2021
- Full Text
- View/download PDF
11. SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes
- Author
-
Nathaniel Moulson, Bradley J. Petek, Jonathan A. Drezner, Kimberly G. Harmon, Stephanie A. Kliethermes, Manesh R. Patel, Aaron L. Baggish, Irfan M. Asif, James Borchers, Katherine M. Edenfield, Michael S. Emery, Kyle Goerl, Brian Hainline, Jonathan H. Kim, William E. Kraus, Rachel Lampert, Matthew Leiszler, Benjamin D. Levine, Matthew W. Martinez, Francis G. O’Connor, Dermot Phelan, Lawrence D. Rink, Herman A. Taylor, Carl Ade, Aryan Aiyer, Jarrah Alfadhli, Chloe Amaradio, Scott Anderson, Stephanie Arlis-Mayor, Jonathan S. Aubry, Andrea Austin, Timothy Beaver, Nicolas Benitez, Brant Berkstresser, Thomas M. Best, Tiffany Bohon, Jonathan P. Bonnet, Elizabeth Boyington, James Bray, Jenna Bryant, Sean Carnahan, Rachel Chamberlain, Samantha Charters, Timothy W. Churchill, Douglas Comeau, Laura E. Cook, Deanna Corey, Amy Costa, Marshall Crowther, Tarun Dalia, Craig Davidson, Kaitlin Davitt, Annabelle De St Maurice, Peter N. Dean, Katelyn DeZenzo, Courtney Dimitris, Jeanne Doperak, Calvin Duffaut, Craig Fafara, Katherine Fahy, Jason Ferderber, Megan Finn, Angelo Galante, Todd Gerlt, Amy Gest, Carla Gilson, Jeffrey Goldberger, Joshua Goldman, Erich Groezinger, Jonathan R. Guin, Heather Halseth, Joshua Hare, Beth Harness, Nicolas Hatamiya, Julie Haylett, Neal Hazen, Yeun Hiroi, Amy Hockenbrock, Amanda Honsvall, Jennifer Hopp, Julia Howard, Samantha Huba, Mustafa Husaini, Lindsay Huston, Calvin Hwang, Laura Irvin, Val Gene Iven, Robert Jones, Donald Joyce, Kristine Karlson, Christian Klein, Chris Klenck, Michele Kirk, Jordan Knight, Laura Knippa, Madeleine Knutson, Louis E. Kovacs, Yumi Kuscher, Andrea Kussman, Chrissy Landreth, Amy Leu, Dylan Lothian, Maureen Lowery, Andrew Lukjanczuk, John M. MacKnight, Lawrence M. Magee, Marja-Liisa Magnuson, Aaron V. Mares, Anne Marquez, Grant McKinley, Megan Meier, Christopher Miles, Emily Miller, Hannah Miller, Raul Mitrani, Robert J. Myerburg, Greg Mytyk, Andrew Narver, Aurelia Nattiv, Laika Nur, Brooke E. Organ, Meredith Pendergast, Frank A. Pettrone, Sourav K. Poddar, Diana Priestman, Ian Quinn, Fred Reifsteck, Morgan Restivo, James B. Robinson, Ryan Roe, Thomas Rosamond, Carrie Rubertino Shearer, Miguel Rueda, Takamasa Sakamoto, Brock Schnebel, Ankit B. Shah, Alan Shahtaji, Kevin Shannon, Polly Sheridan-Young, Siobhan M. Statuta, Mark Stovak, Andrei Tarsici, Kenneth S. Taylor, Kim Terrell, Matt Thomason, Jason Tso, Daniel Vigil, Francis Wang, Jennifer Winningham, and Susanna T. Zorn
- Subjects
medicine.medical_specialty ,2019-20 coronavirus outbreak ,Myocarditis ,Coronavirus disease 2019 (COVID-19) ,Adverse outcomes ,Hospitalized patients ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Competitive athletes ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,Physiology (medical) ,Internal medicine ,Original Research Articles ,medicine ,Humans ,030212 general & internal medicine ,biology ,Athletes ,business.industry ,SARS-CoV-2 ,COVID-19 ,medicine.disease ,biology.organism_classification ,Return to Sport ,athletes ,ComputingMethodologies_DOCUMENTANDTEXTPROCESSING ,myocarditis ,Cardiology and Cardiovascular Medicine ,business - Abstract
Supplemental Digital Content is available in the text., Background: Cardiac involvement among hospitalized patients with severe coronavirus disease 2019 (COVID-19) is common and associated with adverse outcomes. This study aimed to determine the prevalence and clinical implications of COVID-19 cardiac involvement in young competitive athletes. Methods: In this prospective, multicenter, observational cohort study with data from 42 colleges and universities, we assessed the prevalence, clinical characteristics, and outcomes of COVID-19 cardiac involvement among collegiate athletes in the United States. Data were collected from September 1, 2020, to December 31, 2020. The primary outcome was the prevalence of definite, probable, or possible COVID-19 cardiac involvement based on imaging definitions adapted from the Updated Lake Louise Imaging Criteria. Secondary outcomes included the diagnostic yield of cardiac testing, predictors for cardiac involvement, and adverse cardiovascular events or hospitalizations. Results: Among 19 378 athletes tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, 3018 (mean age, 20 years [SD, 1 year]; 32% female) tested positive and underwent cardiac evaluation. A total of 2820 athletes underwent at least 1 element of cardiac triad testing (12-lead ECG, troponin, transthoracic echocardiography) followed by cardiac magnetic resonance imaging (CMR) if clinically indicated. In contrast, primary screening CMR was performed in 198 athletes. Abnormal findings suggestive of SARS-CoV-2 cardiac involvement were detected by ECG (21 of 2999 [0.7%]), cardiac troponin (24 of 2719 [0.9%]), and transthoracic echocardiography (24 of 2556 [0.9%]). Definite, probable, or possible SARS-CoV-2 cardiac involvement was identified in 21 of 3018 (0.7%) athletes, including 15 of 2820 (0.5%) who underwent clinically indicated CMR (n=119) and 6 of 198 (3.0%) who underwent primary screening CMR. Accordingly, the diagnostic yield of CMR for SARS-CoV-2 cardiac involvement was 4.2 times higher for a clinically indicated CMR (15 of 119 [12.6%]) versus a primary screening CMR (6 of 198 [3.0%]). After adjustment for race and sex, predictors of SARS-CoV-2 cardiac involvement included cardiopulmonary symptoms (odds ratio, 3.1 [95% CI, 1.2, 7.7]) or at least 1 abnormal triad test result (odds ratio, 37.4 [95% CI, 13.3, 105.3]). Five (0.2%) athletes required hospitalization for noncardiac complications of COVID-19. During clinical surveillance (median follow-up, 113 days [interquartile range=90 146]), there was 1 (0.03%) adverse cardiac event, likely unrelated to SARS-CoV-2 infection. Conclusions: SARS-CoV-2 infection among young competitive athletes is associated with a low prevalence of cardiac involvement and a low risk of clinical events in short-term follow-up.
- Published
- 2021
12. The role of Popeye domain‐containing protein 1 (POPDC1) in the progression of the malignant phenotype
- Author
-
Alina J. Zorn and Steven Tucker
- Subjects
0301 basic medicine ,Pharmacology ,Cell type ,Cell growth ,Cancer ,Biology ,medicine.disease ,Metastasis ,03 medical and health sciences ,Phenotype ,030104 developmental biology ,0302 clinical medicine ,Cancer stem cell ,Cancer cell ,Cell Adhesion ,medicine ,Cancer research ,Epithelial–mesenchymal transition ,Cell adhesion ,Cell Adhesion Molecules ,030217 neurology & neurosurgery ,Cell Proliferation ,Signal Transduction - Abstract
The Popeye domain-containing protein 1 (POPDC1), a tight junction-associated transmembrane protein with a unique binding site for cAMP, has been shown to act as a tumour suppressor in cancer cells. Through interaction with many downstream effectors and signalling pathways, POPDC1 promotes cell adhesion and inhibits uncontrolled cell proliferation, epithelial-to-mesenchymal transition and metastasis. However, POPDC1 expression is down-regulated in many types of cancer, thereby reducing its tumour-suppressive actions. This review discusses the role of POPDC1 in the progression of the malignant phenotype and highlights the broad range of benefits POPDC1 stabilisation may achieve therapeutically. Cancer stem cells (CSCs) are a key hallmark of malignancies and commonly promote treatment resistance. This article provides a comprehensive overview of CSC signalling mechanisms, many of which have been shown to be regulated by POPDC1 in other cell types, thus suggesting an additional therapeutic benefit for POPDC1-stabilising anti-cancer drugs. LINKED ARTICLES: This article is part of a themed issue on New avenues in cancer prevention and treatment (BJP 75th Anniversary). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.12/issuetoc.
- Published
- 2021
- Full Text
- View/download PDF
13. Influence of high glucose in the expression of miRNAs and IGF1R signaling pathway in human myometrial explants
- Author
-
Telma Maria Tenório Zorn, Ekkehard Schleussner, Jörg Herrmann, Rodolfo R. Favaro, Diana M. Morales-Prieto, Jürgen Sonnemann, and Udo R. Markert
- Subjects
Adult ,0301 basic medicine ,medicine.drug_class ,IGF1R signaling pathway ,Receptor, IGF Type 1 ,Andrology ,03 medical and health sciences ,0302 clinical medicine ,Pregnancy ,Diabetes mellitus ,microRNA ,medicine ,Humans ,PTEN ,Labor, Obstetric ,biology ,CREATINA ,business.industry ,Myometrium ,RNA-Binding Proteins ,Obstetrics and Gynecology ,Embryo ,General Medicine ,Middle Aged ,medicine.disease ,MicroRNAs ,Glucose ,030104 developmental biology ,Estrogen ,030220 oncology & carcinogenesis ,miRNAs ,biology.protein ,Female ,GLUT1 ,General Gynecology ,High glucose ,Signal transduction ,Apoptosis Regulatory Proteins ,business ,Human ,Signal Transduction - Abstract
Purpose Several roles are attributed to the myometrium including sperm and embryo transport, menstrual discharge, control of uterine blood flow, and labor. Although being a target of diabetes complications, the influence of high glucose on this compartment has been poorly investigated. Both miRNAs and IGF1R are associated with diabetic complications in different tissues. Herein, we examined the effects of high glucose on the expression of miRNAs and IGF1R signaling pathway in the human myometrium. Methods Human myometrial explants were cultivated for 48 h under either high or low glucose conditions. Thereafter, the conditioned medium was collected for biochemical analyses and the myometrial samples were processed for histological examination as well as miRNA and mRNA expression profiling by qPCR. Results Myometrial structure and morphology were well preserved after 48 h of cultivation in both high and low glucose conditions. Levels of lactate, creatinine, LDH and estrogen in the supernatant were similar between groups. An explorative screening by qPCR arrays revealed that 6 out of 754 investigated miRNAs were differentially expressed in the high glucose group. Data validation by single qPCR assays confirmed diminished expression of miR-215-5p and miR-296-5p, and also revealed reduced miR-497-3p levels. Accordingly, mRNA levels of IGF1R and its downstream mediators FOXO3 and PDCD4, which are potentially targeted by miR-497-3p, were elevated under high glucose conditions. In contrast, mRNA expression of IGF1, PTEN, and GLUT1 was unchanged. Conclusions The human myometrium responds to short-term exposure (48 h) to high glucose concentrations by regulating the expression of miRNAs, IGF1R and its downstream targets.
- Published
- 2021
- Full Text
- View/download PDF
14. APPLYING LESSONS FROM THE U.S. BOTANICAL CAPACITY ASSESSMENT PROJECT TO ACHIEVE 2020 GLOBAL STRATEGY FOR PLANT CONSERVATION TARGETS
- Author
-
Kramer, Andrea T., Zorn-Arnold, Barbara, and Havens, Kayri
- Published
- 2013
- Full Text
- View/download PDF
15. A Machine Learning Strategy for Drug Discovery Identifies Anti-Schistosomal Small Molecules
- Author
-
Kelley Ma, Danielle E. Skinner, Sean Ekins, Eric K Chen, Shengxi Sun, Kimberley M. Zorn, Nelly El-Sakkary, Daniel H. Foil, Thomas J. Lane, Cecelia L McConnon, Lawrence J. Liu, and Conor R. Caffrey
- Subjects
0301 basic medicine ,Phenotypic screening ,030106 microbiology ,Schistosomiasis ,Biology ,Machine learning ,computer.software_genre ,Bayesian ,Article ,Machine Learning ,03 medical and health sciences ,schistosomiasis ,Drug Discovery ,medicine ,Parasite hosting ,Animals ,Schistosoma ,Developmental stage ,Drug discovery ,business.industry ,Bayes Theorem ,Schistosoma mansoni ,medicine.disease ,biology.organism_classification ,030104 developmental biology ,Infectious Diseases ,Larva ,Hit rate ,phenotypic screen ,Artificial intelligence ,business ,computer - Abstract
Schistosomiasis is a chronic and painful disease of poverty caused by the flatworm parasite Schistosoma. Drug discovery for antischistosomal compounds predominantly employs in vitro whole organism (phenotypic) screens against two developmental stages of Schistosoma mansoni, post-infective larvae (somules) and adults. We generated two rule books and associated scoring systems to normalize 3898 phenotypic data points to enable machine learning. The data were used to generate eight Bayesian machine learning models with the Assay Central software according to parasite's developmental stage and experimental time point (≤24, 48, 72, and >72 h). The models helped predict 56 active and nonactive compounds from commercial compound libraries for testing. When these were screened against S. mansoni in vitro, the prediction accuracy for active and inactives was 61% and 56% for somules and adults, respectively; also, hit rates were 48% and 34%, respectively, far exceeding the typical 1-2% hit rate for traditional high throughput screens.
- Published
- 2021
16. Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids
- Author
-
Guixia Yu, Joseph L. DeRisi, Elaine Hsu, Charles Y. Chiu, Doug Stryke, Yasemin D. Sucu, Eric D. Chow, Benjamin Briggs, Marco Lee, Allan Gopez, Wei Gu, Xianding Deng, Shaun Arevalo, Hannah A. Sample, Amy C. Berger, Gurpreet Ishpuniani, Michael R. Wilson, Scot Federman, Kevin Reyes, Steve Miller, Kelsey C. Zorn, and Candace Wang
- Subjects
Adult ,Male ,0301 basic medicine ,Immunology ,Computational biology ,Biology ,Medical and Health Sciences ,Article ,General Biochemistry, Genetics and Molecular Biology ,DNA sequencing ,03 medical and health sciences ,0302 clinical medicine ,Genetics ,Humans ,Gene ,Pathogen ,Illumina dye sequencing ,Aged ,screening and diagnosis ,Bacteria ,Fungi ,High-Throughput Nucleotide Sequencing ,General Medicine ,Middle Aged ,Ribosomal RNA ,biology.organism_classification ,Body Fluids ,4.1 Discovery and preclinical testing of markers and technologies ,Detection ,Infectious Diseases ,Good Health and Well Being ,030104 developmental biology ,Metagenomics ,030220 oncology & carcinogenesis ,Female ,Nanopore sequencing ,Infection ,Cell-Free Nucleic Acids ,Biotechnology ,4.2 Evaluation of markers and technologies - Abstract
We developed a metagenomic next-generation sequencing (mNGS) test using cell-free DNA from body fluids to identify pathogens. The performance of mNGS testing of 182 body fluids from 160 patients with acute illness was evaluated using two sequencing platforms in comparison to microbiological testing using culture, 16S bacterial PCR and/or 28S–internal transcribed ribosomal gene spacer (28S–ITS) fungal PCR. Test sensitivity and specificity of detection were 79 and 91% for bacteria and 91 and 89% for fungi, respectively, by Illumina sequencing; and 75 and 81% for bacteria and 91 and 100% for fungi, respectively, by nanopore sequencing. In a case series of 12 patients with culture/PCR-negative body fluids but for whom an infectious diagnosis was ultimately established, seven (58%) were mNGS positive. Real-time computational analysis enabled pathogen identification by nanopore sequencing in a median 50-min sequencing and 6-h sample-to-answer time. Rapid mNGS testing is a promising tool for diagnosis of unknown infections from body fluids. A universal method enables high-specificity, unbiased pathogen detection from diverse body fluids using metagenomic sequencing and may accelerate clinical decisions.
- Published
- 2020
- Full Text
- View/download PDF
17. Computational Approaches to Identify Molecules Binding to Mycobacterium tuberculosis KasA
- Author
-
Matthew B. Neiditch, Patricia A Vignaux, Kimberley M. Zorn, Thomas J. Lane, Sean Ekins, Ana C. Puhl, Joel S. Freundlich, and Glenn C. Capodagli
- Subjects
Tuberculosis ,biology ,Chemistry ,Microscale thermophoresis ,General Chemical Engineering ,General Chemistry ,Computational biology ,biology.organism_classification ,medicine.disease ,Small molecule ,Mycobacterium tuberculosis ,Food and drug administration ,Docking (molecular) ,medicine ,Molecule ,Pharmacophore ,QD1-999 - Abstract
Tuberculosis is caused by Mycobacterium tuberculosis (Mtb) and is a deadly disease resulting in the deaths of approximately 1.5 million people with 10 million infections reported in 2018. Recently, a key condensation step in the synthesis of mycolic acids was shown to require β-ketoacyl-ACP synthase (KasA). A crystal structure of KasA with the small molecule DG167 was recently described, which provided a starting point for using computational structure-based approaches to identify additional molecules binding to this protein. We now describe structure-based pharmacophores, docking and machine learning studies with Assay Central as a computational tool for the identification of small molecules targeting KasA. We then tested these compounds using nanoscale differential scanning fluorimetry and microscale thermophoresis. Of note, we identified several molecules including the Food and Drug Administration (FDA)-approved drugs sildenafil and flubendazole with K d values between 30-40 μM. This may provide additional starting points for further optimization.
- Published
- 2020
18. Impact of surgical wait times during summer months on the oncological outcomes following robotic-assisted radical prostatectomy: 10 years’ experience from a large Canadian academic center
- Author
-
Kevin C. Zorn, Assaad El-Hakim, Malek Meskawi, Hanna Shahine, Franziska Stolzenbach, Côme Tholomier, Félix Couture, Pierre I. Karakiewicz, David-Dan Nguyen, and Ahmed S. Zakaria
- Subjects
Male ,Biochemical recurrence ,Canada ,medicine.medical_specialty ,Waiting Lists ,Robotic assisted ,Biopsy ,Urology ,medicine.medical_treatment ,030232 urology & nephrology ,Risk Assessment ,Health Services Accessibility ,Time-to-Treatment ,03 medical and health sciences ,0302 clinical medicine ,Risk groups ,Robotic Surgical Procedures ,Outcome Assessment, Health Care ,medicine ,Humans ,Aged ,Neoplasm Staging ,Prostatectomy ,Health Services Needs and Demand ,biology ,business.industry ,General surgery ,Prostatic Neoplasms ,biology.organism_classification ,Wait time ,030220 oncology & carcinogenesis ,Cohort ,Seasons ,Neoplasm Recurrence, Local ,Capra ,business ,Cohort study - Abstract
Most Canadian hospitals face significant reductions in operating room access during the summer. We sought to assess the impact of longer wait times on the oncological outcomes of localized prostate cancer patients following robotic-assisted radical prostatectomy (RARP). We conducted a retrospective review of a prospectively maintained RARP database in two high-volume academic centers, between 2010 and 2019. Assessed outcomes included the difference between post-biopsy UCSF-CAPRA and post-surgical CAPRA-S scores, Gleason score upgrade and biochemical recurrence rates (BCR). Multivariable regression analyses (MVA) were used to evaluate the effect of wait times. A total of 1057 men were included for analysis. Consistent over a 10 year period, summer months had the lowest surgical volumes despite above average booking volumes. The lowest surgical volume occurred during the month of July (7.1 cases on average), which was 35% less than the cohort average. The longest average wait times occurred for patients booked in June (93 ± 69 days, p
- Published
- 2020
- Full Text
- View/download PDF
19. De novo mutations in idiopathic male infertility—A pilot study
- Author
-
P Noveski, Momcilo Ristanovic, Marija Terzic, Dijana Plaseska-Karanfilska, Aleš Maver, Tanja Kunej, Alenka Hodžić, Branko Zorn, and Borut Peterlin
- Subjects
Male ,Candidate gene ,Urology ,Endocrinology, Diabetes and Metabolism ,Pilot Projects ,Biology ,Frameshift mutation ,Male infertility ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Exome Sequencing ,medicine ,Humans ,Point Mutation ,Missense mutation ,Gene ,Infertility, Male ,Genetics ,Azoospermia ,030219 obstetrics & reproductive medicine ,medicine.disease ,3. Good health ,Gene expression profiling ,Reproductive Medicine ,Human genome - Abstract
STUDY QUESTION Are de novo mutations in the human genome associated with male infertility? SUMMARY ANSWER We identified de novo mutations in five candidate genes: SEMA5A, NEURL4, BRD2, CD1D, and CD63. WHAT IS KNOWN ALREADY Epidemiological and genetic studies have consistently indicated contribution of genetic factors to the etiology of male infertility, suggesting that more than 1500 genes are involved in spermatogenesis. STUDY DESIGN, SIZE, DURATION First, we searched for de novo mutations in patients with idiopathic azoospermia with whole-exome sequencing (WES). To evaluate the potential functional impact of de novo identified mutations, we analyzed their expression differences on independent testis samples with normal and impaired spermatogenesis. In the next step, we tested additional group of azoospermic patients for mutations in identified genes with de novo mutations. In addition to the analysis of de novo mutations in patients with idiopathic azoospermia, we considered other models of inheritance and searched for candidate genes harboring rare maternally inherited variants and biallelic autosomal and X-chromosome hemizygous variants. PARTICIPANTS/MATERIALS, SETTING, METHODS We performed WES in 13 infertile males with idiopathic azoospermia and their parents. Potential functional impact of de novo identified mutations was evaluated by global gene expression profiling on 20 independent testis samples. To replicate the results, we performed WES in further 16 independent azoospermic males, which were screened for the variants in the same genes. Library preparation was performed with Nextera Coding Exome Capture Kit (Illumina), with subsequent sequencing on Illumina HiSeq 2500 platform. MAIN RESULTS AND THE ROLE OF CHANCE We identified 11 de novo mutations in 10 genes of which 5 were considered potentially associated with azoospermia: SEMA5A, NEURL4, BRD2, CD1D, and CD63. All candidate genes showed significant differential expression in testis samples composed of patients with severely impaired and normal spermatogenesis. Additionally, we identified rare, potentially pathogenic mutations in the genes previously implicated in male infertility-a maternally inherited heterozygous frameshift variant in FKBPL gene and inframe deletion in UPF2 gene, homozygous frameshift variant in CLCA4 gene, and a heterozygous missense variant NR0B1 gene, which represent promising candidates for further clinical implication. LIMITATIONS OF THE STUDY, REASONS FOR CAUTION We provided limited functional support for involvement of de novo identified genes in pathogenesis of male infertility, based on expression analysis. Additionally, the sample size was limited. WIDER IMPLICATIONS OF THE FINDINGS We provide support that de novo mutations might contribute to male infertility and propose five genes as potentially implicated in its pathogenesis.
- Published
- 2020
- Full Text
- View/download PDF
20. Does Light Color Temperature Influence Aspects of Oviposition by the Black Soldier Fly (Diptera: Stratiomyidae)?
- Author
-
Martin Rühl, Daniel Bakonyi, Patrick Klüber, and Holger Zorn
- Subjects
0106 biological sciences ,Hermetia illucens ,Oviposition ,media_common.quotation_subject ,Stratiomyidae ,Color temperature ,Biology ,010603 evolutionary biology ,01 natural sciences ,Soldier fly ,Animals ,Mating ,media_common ,Larva ,Ecology ,Artificial light ,Diptera ,Reproduction ,Temperature ,General Medicine ,biology.organism_classification ,010602 entomology ,Horticulture ,Insect Science ,Female - Abstract
In recent years, black soldier fly, Hermetia illucens (L.), larvae have attracted increasing attention because of their high capacity for bioconversion of diverse organic material into high-quality protein and lipids. Although previous studies have focused on optimization of breeding conditions, such as the acceptance of substrates, and temperatures and moisture contents, little is known about light-dependent adult development. Artificial light sources are important to commercial H. illucens breeding, especially at latitudes with short days in autumn and winter months. We examined how 3,000, 4,000, and 6,500 K color temperatures affect aspects of oviposition. Mating occurred under all of the broad spectrum light-emitting diode panels, resulting in fertilized egg clusters. Oviposition lasted up to 15 d, while the shortest oviposition period, in the 3,000 K light treatment, was 2 d. Total oviposition performance and oviposition period were not affected by the light treatments. Oviposition peaked 1–7 d after eggs were first deposited. The time until oviposition peaked was positively correlated with increasing color temperature.
- Published
- 2020
- Full Text
- View/download PDF
21. Profiling non-HLA antibody responses in antibody-mediated rejection following heart transplantation
- Author
-
E. Rodica Vasilescu, Linda J. Addonizio, Bryan Ray, Emmanuel Zorn, Charles C. Marboe, Kevin J. Clerkin, Maryjane Farr, Sarah B. See, Benjamin S. Mantell, Susan Restaino, Paolo C. Colombo, and Yoshifumi Naka
- Subjects
Graft Rejection ,Apolipoprotein L2 ,medicine.medical_treatment ,Vimentin ,Human leukocyte antigen ,030230 surgery ,Article ,03 medical and health sciences ,0302 clinical medicine ,Antigen ,HLA Antigens ,Isoantibodies ,Humans ,Immunology and Allergy ,Medicine ,Pharmacology (medical) ,Heart transplantation ,Transplantation ,biology ,business.industry ,Autoantibody ,Tissue Donors ,body regions ,Antibody Formation ,Immunology ,biology.protein ,Heart Transplantation ,Antibody ,business - Abstract
Antibody-mediated rejection (AMR) driven by the development of donor-specific antibodies (DSA) directed against mismatched donor human leukocyte antigen (HLA) is a major risk factor for graft loss in cardiac transplantation. Recently, the relevance of non-HLA antibodies has become more prominent as AMR can be diagnosed in the absence of circulating DSA. Here, we assessed a single-center cohort of 64 orthotopic heart transplant recipients transplanted between 1994 and 2014. Serum collected from patients with ≥ pAMR1 (n = 43) and non-AMR (n = 21) were tested for reactivity against a panel of 44 non-HLA autoantigens. The AMR group had a significantly greater percentage of patients with elevated reactivity to autoantigens compared to non-AMR (P = .002) and healthy controls (n = 94, P .0001). DSA-positive AMR patients exhibited greater reactivity to autoantigens compared to DSA-negative (P .0001) and AMR patients with DSA and PRA 10% were identified as the subgroup with significantly elevated responses. Reactivity to 4 antigens, vimentin, beta-tubulin, lamin A/C, and apolipoprotein L2, was significantly different between AMR and non-AMR patients. Moreover, increased reactivity to these antigens was associated with graft failure. These results suggest that antibodies to non-HLA are associated with DSA-positive AMR although their specific role in mediating allograft injury is not yet understood.
- Published
- 2020
- Full Text
- View/download PDF
22. Highlights of the 12th Wartburg Symposium on Flavor Chemistry & Biology
- Author
-
Thomas Hofmann, Holger Zorn, and Corinna Dawid
- Subjects
Chemistry ,Library science ,General Chemistry ,Chemistry (relationship) ,Biology ,General Agricultural and Biological Sciences ,Flavor - Abstract
The 12th Wartburg Symposium on Flavor Chemistry & Biology was held at the hotel “Auf der Wartburg” in Eisenach, Germany, from May 21 to 24, 2019. It offered a unique venue for global exchange on cu...
- Published
- 2020
- Full Text
- View/download PDF
23. Increasing connectivity of Great Lakes tributaries: Interspecific and intraspecific effects on resident brook trout and brown trout populations
- Author
-
Jan-Michael Hessenauer, Todd C. Wills, and Troy G. Zorn
- Subjects
0106 biological sciences ,geography.geographical_feature_category ,Ecology ,biology ,010604 marine biology & hydrobiology ,Ecology (disciplines) ,Interspecific competition ,Aquatic Science ,biology.organism_classification ,010603 evolutionary biology ,01 natural sciences ,Intraspecific competition ,Brown trout ,Trout ,Geography ,Tributary ,Freshwater fish ,Table (landform) ,Ecology, Evolution, Behavior and Systematics - Abstract
The above article from the Ecology of Freshwater Fish, published online on 20 December 2019 in Wiley Online Library (https://onlinelibrary.wiley.com/doi/abs/10.1111/eff.12527), has been retracted by agreement between the journal Editor‐in‐Chief; the symposium editor, Phaedra Budy; and the author, Troy Zorn. The retraction has been made due to a mistake in the classification (accessible vs. landlocked) of one of the survey locations in Table 1, which affected the accuracy of other analyses in the article.
- Published
- 2020
- Full Text
- View/download PDF
24. Genetic Structure of Smallmouth Bass in the Lake Michigan and Upper Mississippi River Drainages Relates to Habitat, Distance, and Drainage Boundaries
- Author
-
David Rowe, Peter T. Euclide, Jenna Ruzich, Wesley A. Larson, Troy G. Zorn, and Scott P. Hansen
- Subjects
food.ingredient ,biology ,Population genetics ,Aquatic Science ,biology.organism_classification ,Fishery ,Bass (fish) ,food ,Black bass ,Habitat ,Genetic structure ,Drainage ,Ecology, Evolution, Behavior and Systematics ,Isolation by distance - Published
- 2020
- Full Text
- View/download PDF
25. The scaffold protein p62 regulates adaptive thermogenesis through ATF2 nuclear target activation
- Author
-
Jens C. Brüning, Susanne Keipert, Bernd J. Pichler, Julia Zorn, Martin Klingenspor, Ines Pramme-Steinwachs, Siegfried Ussar, Martin Jastroch, Maria T. Diaz-Meco, Anna Fedl, Florian C. Maier, Markus Brielmeier, Jianfeng Huang, Stephan Sachs, Ahmed E. Othman, Henriette Uhlenhaut, Anna Fenzl, Jorge Moscat, M. H. Tschöp, Wolfgang M. Thaiss, Brian Finan, Maximilian Kleinert, Timo D. Müller, Kenneth A. Dyar, Manfred Kneilling, Stephen C. Woods, Angelika Scheideler, Dianxin Liu, Kerstin Stemmer, Christoffer Clemmensen, Katrin Fischer, Sheila Collins, and André Gessner
- Subjects
0301 basic medicine ,Scaffold protein ,Male ,Transcriptional regulatory elements ,Metabolic disorders ,General Physics and Astronomy ,Adipose tissue ,p38 Mitogen-Activated Protein Kinases ,Mice ,0302 clinical medicine ,Adipose Tissue, Brown ,Positron Emission Tomography Computed Tomography ,Brown adipose tissue ,Sequestosome-1 Protein ,lcsh:Science ,Uncoupling Protein 1 ,Mice, Knockout ,Multidisciplinary ,Adipogenesis ,biology ,Chemistry ,Magnetic Resonance Imaging ,Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha ,Activating transcription factor 2 ,Cell biology ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Phosphorylation ,Protein Binding ,Adipose Tissue, White ,Science ,Alpha (ethology) ,General Biochemistry, Genetics and Molecular Biology ,Article ,03 medical and health sciences ,ddc:570 ,medicine ,Animals ,ddc:610 ,Obesity ,Enhancer ,Cell Nucleus ,Activating Transcription Factor 2 ,General Chemistry ,Mice, Inbred C57BL ,030104 developmental biology ,biology.protein ,lcsh:Q ,Thermogenesis - Abstract
During β-adrenergic stimulation of brown adipose tissue (BAT), p38 phosphorylates the activating transcription factor 2 (ATF2) which then translocates to the nucleus to activate the expression of Ucp1 and Pgc-1α. The mechanisms underlying ATF2 target activation are unknown. Here we demonstrate that p62 (Sqstm1) binds to ATF2 to orchestrate activation of the Ucp1 enhancer and Pgc-1α promoter. P62Δ69-251 mice show reduced expression of Ucp1 and Pgc-1α with impaired ATF2 genomic binding. Modulation of Ucp1 and Pgc-1α expression through p62 regulation of ATF2 signaling is demonstrated in vitro and in vivo in p62Δ69-251 mice, global p62−/− and Ucp1-Cre p62flx/flx mice. BAT dysfunction resulting from p62 deficiency is manifest after birth and obesity subsequently develops despite normal food intake, intestinal nutrient absorption and locomotor activity. In summary, our data identify p62 as a master regulator of BAT function in that it controls the Ucp1 pathway through regulation of ATF2 genomic binding., Beta-adrenergic stimulation of brown adipose tissue leads to thermogenesis via the activating transcription factor 2 (ATF2) mediated expression of the thermogenic genes Ucp1 and Pgc-1α. Here, the authors show that the scaffold protein p62 regulates brown adipose tissue function through modifying ATF2 genomic binding and subsequent Ucp1 and Pgc-1α induction.
- Published
- 2020
- Full Text
- View/download PDF
26. Effects of White Sucker Removal and Stocking on Growth of Fishes in Northern Lakes
- Author
-
Mark S. Mylchreest, Troy G. Zorn, and Arnold W. Abrahamson
- Subjects
Fishery ,Stocking ,Ecology ,Management, Monitoring, Policy and Law ,Aquatic Science ,Biology ,White sucker ,biology.organism_classification ,Ecology, Evolution, Behavior and Systematics - Published
- 2020
- Full Text
- View/download PDF
27. Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice
- Author
-
Telma Maria Tenório Zorn, Aline David-Silva, H. S. Freitas, João Victor Del Conti Esteves, Maria Lúcia Corrêa-Giannella, Mychel R. P. T. Morais, and Ubiratan Fabres Machado
- Subjects
Pharmacology ,medicine.medical_specialty ,Hepatic glucose ,biology ,Phlorizin ,business.industry ,Fatty liver ,030209 endocrinology & metabolism ,Non alcoholic ,Diabetic mouse ,030204 cardiovascular system & hematology ,medicine.disease ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Endocrinology ,chemistry ,Internal medicine ,Internal Medicine ,medicine ,biology.protein ,GLUT2 ,SGLT2 Inhibitor ,Phosphoenolpyruvate carboxykinase ,business - Abstract
Sao Paulo State Foundation for Research (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/15603-0]
- Published
- 2020
- Full Text
- View/download PDF
28. Uncovering the mesendoderm gene regulatory network through multi-omic data integration
- Author
-
Ira L. Blitz, Rebekah M. Charney, Margaret B. Fish, Camden Jansen, Kitt D. Paraiso, Jeff Jiajing Zhou, Aaron M. Zorn, Yuuri Yasuoka, Gert Jan C. Veenstra, Ali Mortazavi, M. Wlizla, Jin Sun Cho, Ann Rose Bright, Ken W.Y. Cho, Norihiro Sudou, and Masanori Taira
- Subjects
Transcription, Genetic ,Computer science ,Cellular differentiation ,Xenopus ,Medical Physiology ,Gene regulatory network ,computer.software_genre ,Mesoderm ,Transcriptional regulation ,Developmental ,Gene Regulatory Networks ,biology ,Endoderm ,Vertebrate ,Gene Expression Regulation, Developmental ,Genomics ,ATAC-seq ,Chromatin ,ChIP-seq ,Stem Cell Research - Nonembryonic - Non-Human ,Molecular Developmental Biology ,Transcription ,Data integration ,Protein Binding ,Biotechnology ,Cell signaling ,Pediatric Research Initiative ,1.1 Normal biological development and functioning ,Computational biology ,Cell fate determination ,General Biochemistry, Genetics and Molecular Biology ,linked self-organizing maps ,Genetic ,Underpinning research ,biology.animal ,cis-regulatory modules ,Consensus Sequence ,Genetics ,Animals ,endoderm ,Transcription factor ,multi-omic ,Embryogenesis ,Gastrulation ,Human Genome ,DNA ,biology.organism_classification ,Stem Cell Research ,Gene Expression Regulation ,RNA ,Generic health relevance ,Biochemistry and Cell Biology ,RNA-seq ,computer ,Transcription Factors - Abstract
SummaryMesendodermal specification is one of the earliest events in embryogenesis, where cells first acquire distinct identities. Cell differentiation is a highly regulated process that involves the function of numerous transcription factors (TFs) and signaling molecules, which can be described with gene regulatory networks (GRNs). Cell differentiation GRNs are difficult to build because existing mechanistic methods are low-throughput, and high-throughput methods tend to be non-mechanistic. Additionally, integrating highly dimensional data comprised of more than two data types is challenging. Here, we use linked self-organizing maps to combine ChIP-seq/ATAC-seq with temporal, spatial and perturbation RNA-seq data fromXenopus tropicalismesendoderm development to build a high resolution genome scale mechanistic GRN. We recovered both known and previously unsuspected TF-DNA/TF-TF interactions and validated through reporter assays. Our analysis provides new insights into transcriptional regulation of early cell fate decisions and provides a general approach to building GRNs using highly-dimensional multi-omic data sets.HighlightsBuilt a generally applicable pipeline to creating GRNs using highly-dimensional multi-omic data setsPredicted new TF-DNA/TF-TF interactions during mesendoderm developmentGenerate the first genome scale GRN for vertebrate mesendoderm and expanded the core mesendodermal developmental network with high fidelityDeveloped a resource to visualize hundreds of RNA-seq and ChIP-seq data using 2D SOM metaclusters.
- Published
- 2022
29. Functional human gastrointestinal organoids can be engineered from three primary germ layers separately derived from pluripotent system cells
- Author
-
Daniel O Kechele, Keishi Kishimoto, Aaron M. Zorn, Nambirajan Sundaram, H. Matthew Berns, Lauren E. Haines, Mansa Krishnamurthy, Alexandra K. Eicher, Michael A. Helmrath, Lu Han, James M. Wells, J. Guillermo Sanchez, and Holly M. Poling
- Subjects
Pluripotent Stem Cells ,Cell type ,Mesenchyme ,Endoderm ,Mesenchymal stem cell ,Stomach ,Neural crest ,Cell Differentiation ,Cell Biology ,Germ layer ,Biology ,Models, Biological ,Article ,Cell biology ,Organoids ,medicine.anatomical_structure ,Tissue engineering ,Neural Crest ,Genetics ,Organoid ,medicine ,Molecular Medicine ,Humans ,Induced pluripotent stem cell ,Germ Layers - Abstract
Summary Human organoid model systems lack important cell types that, in the embryo, are incorporated into organ tissues during development. We developed an organoid assembly approach starting with cells from the three primary germ layers—enteric neuroglial, mesenchymal, and epithelial precursors—that were derived separately from human pluripotent stem cells (PSCs). From these three cell types, we generated human antral and fundic gastric tissue containing differentiated glands surrounded by layers of smooth muscle containing functional enteric neurons that controlled contractions of the engineered antral tissue. Using this experimental system, we show that human enteric neural crest cells (ENCCs) promote mesenchyme development and glandular morphogenesis of antral stomach organoids. Moreover, ENCCs can act directly on the foregut to promote a posterior fate, resulting in organoids with a Brunner's gland phenotype. Thus, germ layer components that are derived separately from PSCs can be used for tissue engineering to generate complex human organoids.
- Published
- 2021
30. Genomic evolution of antimicrobial resistance in Escherichia coli
- Author
-
Leekitcharoenphon, Pimlapas, Johansson, Markus Hans Kristofer, Munk, Patrick, Malorny, Burkhard, Skarzynska, Magdalena, Wadepohl, Katharina, Moyano, Gabriel, Hesp, Ayla, Veldman, Kees T., Bossers, Alex, Graveland, Haitske, van Essen, Alieda, Battisti, Antonio, Caprioli, Andrea, Blaha, Thomas, Hald, Tine, Daskalov, Hristo, Saatkamp, Helmut W., Staerk, Katharina D. C., Luiken, Roosmarijn E. C., Van Gompel, Liese, Hansen, Rasmus Borup, Dewulf, Jeroen, Duarte, Ana Sofia Ribeiro, Zajac, Magdalena, Wasyl, Dariusz, Sanders, Pascal, Gonzalez-Zorn, Bruno, Brouwer, Michael S. M., Wagenaar, Jaap A., Heederik, Dick J. J., Mevius, Dik, Aarestrup, Frank M., EFFORT Consortium, for the, Technical University of Denmark [Lyngby] (DTU), Bundesinstitut für Risikobewertung - Federal Institute for Risk Assessment (BfR), Universidad Complutense de Madrid = Complutense University of Madrid [Madrid] (UCM), Wageningen BioVeterinary Research, Wageningen University and Research [Wageningen] (WUR), Laboratoire de Fougères - ANSES, Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES), European Project: 613754,EC:FP7:KBBE,FP7-KBBE-2013-7-single-stage,EFFORT(2013), Danmarks Tekniske Universitet = Technical University of Denmark (DTU), IRAS OH Epidemiology Microbial Agents, Klinische infectiologie en microb. lab., dI&I I&I-4, dIRAS RA-I&I RA, and Faculteit Diergeneeskunde
- Subjects
0301 basic medicine ,Genomic alteration ,antibiotic resistance ,Swine ,Epidemiology ,résistance aux antibiotiques ,veterinary drug ,medicine.disease_cause ,Genome ,Poultry ,Feces ,animal ,évolution ,bacteria ,Escherichia coli Infections ,Phylogeny ,médicament humainélevage ,2. Zero hunger ,Genetics ,human drug ,bactérie ,Multidisciplinary ,Virulence ,Bacteriologie ,transmission ,Genomics ,Bacteriology, Host Pathogen Interaction & Diagnostics ,Text ,Anti-Bacterial Agents ,Europe ,Medicine ,médicament ,médicament vétérinaire ,Bioinformatica & Diermodellen ,Science ,030106 microbiology ,Microbial Sensitivity Tests ,GENETIC-STRUCTURE ,Biology ,Article ,Evolution, Molecular ,03 medical and health sciences ,Antibiotic resistance ,résistance aux antimicrobiens ,Drug Resistance, Bacterial ,Bio-informatics & Animal models ,medicine ,Escherichia coli ,Animals ,Life Science ,Epidemiology, Bio-informatics & Animal models ,ddc:610 ,Veterinary Sciences ,antimicrobial resistance ,microbiologie ,General ,genome ,Host Pathogen Interaction & Diagnostics ,Epidemiologie ,Whole genome sequencing ,génome ,microbiology ,Bacteriology ,[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology ,Host Pathogen Interactie & Diagnostiek ,livestock ,Red Meat ,030104 developmental biology ,Metagenomics ,Genetic marker ,Epidemiologie, Bioinformatica & Diermodellen ,Bacteriologie, Host Pathogen Interactie & Diagnostiek ,Molecular evolution ,Cattle ,POULTRY ,Mobile genetic elements ,humain ,Genome, Bacterial - Abstract
The emergence of antimicrobial resistance (AMR) is one of the biggest health threats globally. In addition, the use of antimicrobial drugs in humans and livestock is considered an important driver of antimicrobial resistance. The commensal microbiota, and especially the intestinal microbiota, has been shown to have an important role in the emergence of AMR. Mobile genetic elements (MGEs) also play a central role in facilitating the acquisition and spread of AMR genes. We isolated Escherichia coli (n = 627) from fecal samples in respectively 25 poultry, 28 swine, and 15 veal calf herds from 6 European countries to investigate the phylogeny of E. coli at country, animal host and farm levels. Furthermore, we examine the evolution of AMR in E. coli genomes including an association with virulence genes, plasmids and MGEs. We compared the abundance metrics retrieved from metagenomic sequencing and whole genome sequenced of E. coli isolates from the same fecal samples and farms. The E. coli isolates in this study indicated no clonality or clustering based on country of origin and genetic markers; AMR, and MGEs. Nonetheless, mobile genetic elements play a role in the acquisition of AMR and virulence genes. Additionally, an abundance of AMR was agreeable between metagenomic and whole genome sequencing analysis for several AMR classes in poultry fecal samples suggesting that metagenomics could be used as an indicator for surveillance of AMR in E. coli isolates and vice versa.
- Published
- 2021
- Full Text
- View/download PDF
31. Evolution of ColE1-like plasmids across γ-Proteobacteria: From bacteriocin production to antimicrobial resistance
- Author
-
Manuel Ares-Arroyo, Eduardo P. C. Rocha, Bruno Gonzalez-Zorn, Universidad Complutense de Madrid = Complutense University of Madrid [Madrid] (UCM), Génomique évolutive des Microbes / Microbial Evolutionary Genomics, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), B.G.Z. was supported by grants from the European Joint Program One Health EJP, ARDIG Grant Agreement No 77380, from the European Union’s Horizon 2020 research and innovation program. M.A.A. was supported by the Universidad Complutense de Madrid (Grant ID CT27/16-CT28/16 and EB14/19). E.P.C.R. acknowledges the financial support of Equipe FRM (EQU201903007835) and the Laboratoire d’Excellence IBEID (ANR-10-LABX-62-IBEID)., ANR-10-LABX-0062,IBEID,Integrative Biology of Emerging Infectious Diseases(2010), and European Project: 773830, H2020-SFS-2017-1 ,One Health EJP(2018)
- Subjects
Evolutionary Genetics ,Cancer Research ,Relaxases ,Molecular biology ,Markov models ,Genome ,Biochemistry ,Plasmid ,Bacteriocins ,Mobile Genetic Elements ,Medicine and Health Sciences ,Replicon ,Hidden Markov models ,Genetics (clinical) ,Phylogeny ,Data Management ,Genetics ,ColE1 ,Phylogenetic tree ,[SDV.BID.EVO]Life Sciences [q-bio]/Biodiversity/Populations and Evolution [q-bio.PE] ,Phylogenetic Analysis ,Genomics ,[SDV.BIBS]Life Sciences [q-bio]/Quantitative Methods [q-bio.QM] ,Markov Chains ,Enzymes ,Anti-Bacterial Agents ,Phylogenetics ,Nucleic acids ,Physical sciences ,Gammaproteobacteria ,Research Article ,Plasmids ,Computer and Information Sciences ,Forms of DNA ,Biology ,DNA construction ,Microbiology ,Evolution, Molecular ,Genetic Elements ,Bacterial Proteins ,Microbial Control ,[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN] ,Drug Resistance, Bacterial ,Evolutionary Systematics ,Gene ,Ecology, Evolution, Behavior and Systematics ,Taxonomy ,Pharmacology ,Evolutionary Biology ,Bacterial Evolution ,[SDV.GEN.GPO]Life Sciences [q-bio]/Genetics/Populations and Evolution [q-bio.PE] ,Human evolutionary genetics ,Biology and Life Sciences ,Proteins ,Probability theory ,Bacteriology ,DNA ,[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology ,Organismal Evolution ,Research and analysis methods ,Molecular biology techniques ,Genes, Bacterial ,Plasmid Construction ,Microbial Evolution ,Enzymology ,bacteria ,Antimicrobial Resistance ,Mobile genetic elements ,[INFO.INFO-BI]Computer Science [cs]/Bioinformatics [q-bio.QM] ,Mathematics - Abstract
Antimicrobial resistance is one of the major threats to Public Health worldwide. Understanding the transfer and maintenance of antimicrobial resistance genes mediated by mobile genetic elements is thus urgent. In this work, we focus on the ColE1-like plasmid family, whose distinctive replication and multicopy nature has given rise to key discoveries and tools in molecular biology. Despite being massively used, the hosts, functions, and evolutionary history of these plasmids remain poorly known. Here, we built specific Hidden Markov Model (HMM) profiles to search ColE1 replicons within genomes. We identified 1,035 ColE1 plasmids in five Orders of γ-Proteobacteria, several of which are described here for the first time. The phylogenetic analysis of these replicons and their characteristic MOBP5/HEN relaxases suggest that ColE1 plasmids have diverged apart, with little transfer across orders, but frequent transfer across families. Additionally, ColE1 plasmids show a functional shift over the last decades, losing their characteristic bacteriocin production while gaining several antimicrobial resistance genes, mainly enzymatic determinants and including several extended-spectrum betalactamases and carbapenemases. Furthermore, ColE1 plasmids facilitate the intragenomic mobilization of these determinants, as various replicons were identified co-integrated with large non-ColE1 plasmids, mostly via transposases. These results illustrate how families of plasmids evolve and adapt their gene repertoires to bacterial adaptive requirements., Author summary The extraordinary adaptability of bacteria and the massive prevalence of mobile genetic elements within populations has turned antimicrobial resistance into a growing threat to Public Health. Among all the mobile genetic elements, plasmids have been the focus of attention as these extrachromosomal molecules of DNA are able to mobilize several antimicrobial resistance genes at once through conjugation. However, although small mobilizable and non-conjugative replicons have been traditionally overlooked when analyzing plasmid-mediated antimicrobial resistance, they have recently been described as important carriers of AMR genes. In this work, we have analyzed the ColE1-like plasmid family, whose study has been neglected even if they are one of the main groups of small plasmids in natural populations of Proteobacteria. We observed that these plasmids have evolved for a long time within γ-Proteobacteria acquiring different genetic features in specific hosts, being major players in the spread of antimicrobial resistance determinants.
- Published
- 2021
- Full Text
- View/download PDF
32. Description of a new species and new faunistic records of the genus Anomala SAMOUELLE (Coleoptera, Scarabaeidae, Rutelinae) from China and neighboring regions
- Author
-
Wang, Fa-Lei and Zorn, Carsten
- Subjects
Pulmonary and Respiratory Medicine ,Scarabaeidae ,Insecta ,biology ,Arthropoda ,Biodiversity ,biology.organism_classification ,Rutelinae ,Coleoptera ,Geography ,Genus ,Pediatrics, Perinatology and Child Health ,Botany ,Rutelidae ,Animalia ,Anomala ,China ,Taxonomy - Abstract
Anomala xiongi Wang & Zorn spec. nov. is described from Yunnan, China. This new species can be distinguished from all other known Anomala species by conspicuous long erect setae rising from the primary costae of elytra. Additionally, ten new distributional records of Anomala species from China and neighboring countries are provided. Nomenclatural act Anomala xiongi Wang & Zorn spec. nov. – urn:lsid:zoobank.org:act:F10AD66D-BEF8-41E2-B22D-42D0492D9E95, Contributions to Entomology = Beiträge zur Entomologie, Bd. 71 Nr. 1 (2021)
- Published
- 2021
33. Tbx5 drives Aldh1a2 expression to regulate a RA-Hedgehog-Wnt gene regulatory network coordinating cardiopulmonary development
- Author
-
Scott A. Rankin, Ivan P. Moskowitz, Ariel B. Rydeen, Kunal Agarwal, Praneet Chaturvedi, Michael J Herriges, Xinan Yang, Aaron M. Zorn, Jeffrey D. Steimle, and Kohta Ikegami
- Subjects
Mesoderm ,animal structures ,QH301-705.5 ,Xenopus ,cardiopulmonary ,Science ,Biology ,Xenopus Proteins ,General Biochemistry, Genetics and Molecular Biology ,Aldehyde Dehydrogenase 1 Family ,Mice ,Xenopus laevis ,medicine ,retinoic acid ,Animals ,Gene Regulatory Networks ,Sonic hedgehog ,Biology (General) ,Enhancer ,Hedgehog ,Lung ,mouse ,lung development ,General Immunology and Microbiology ,Base Sequence ,General Neuroscience ,Lateral plate mesoderm ,Wnt signaling pathway ,Gene Expression Regulation, Developmental ,Retinal Dehydrogenase ,Genetics and Genomics ,Heart ,General Medicine ,Hedgehog signaling pathway ,Cell biology ,medicine.anatomical_structure ,embryonic structures ,biology.protein ,Tbx5 transcription factor ,Medicine ,Endoderm ,T-Box Domain Proteins ,Sequence Alignment ,Research Article ,Developmental Biology - Abstract
The gene regulatory networks that coordinate the development of the cardiac and pulmonary systems are essential for terrestrial life but poorly understood. The T-box transcription factor Tbx5 is critical for both pulmonary specification and heart development, but how these activities are mechanistically integrated remains unclear. Here using Xenopus and mouse embryos, we establish molecular links between Tbx5 and retinoic acid (RA) signaling in the mesoderm and between RA signaling and sonic hedgehog expression in the endoderm to unveil a conserved RA-Hedgehog-Wnt signaling cascade coordinating cardiopulmonary (CP) development. We demonstrate that Tbx5 directly maintains expression of aldh1a2, the RA-synthesizing enzyme, in the foregut lateral plate mesoderm via an evolutionarily conserved intronic enhancer. Tbx5 promotes posterior second heart field identity in a positive feedback loop with RA, antagonizing a Fgf8-Cyp regulatory module to restrict FGF activity to the anterior. We find that Tbx5/Aldh1a2-dependent RA signaling directly activates shh transcription in the adjacent foregut endoderm through a conserved MACS1 enhancer. Hedgehog signaling coordinates with Tbx5 in the mesoderm to activate expression of wnt2/2b, which induces pulmonary fate in the foregut endoderm. These results provide mechanistic insight into the interrelationship between heart and lung development informing CP evolution and birth defects.
- Published
- 2021
34. Author response: Tbx5 drives Aldh1a2 expression to regulate a RA-Hedgehog-Wnt gene regulatory network coordinating cardiopulmonary development
- Author
-
Scott A. Rankin, Xinan Yang, Jeffrey D. Steimle, Praneet Chaturvedi, Ivan P. Moskowitz, Michael J Herriges, Kunal Agarwal, Aaron M. Zorn, Kohta Ikegami, and Ariel B. Rydeen
- Subjects
Expression (architecture) ,Wnt signaling pathway ,Gene regulatory network ,Biology ,Hedgehog ,Cell biology ,ALDH1A2 - Published
- 2021
- Full Text
- View/download PDF
35. SARS-CoV-2 variant exposures elicit antibody responses with differential cross-neutralization of established and emerging strains including Delta and Omicron
- Author
-
Matthew T Laurie, Jamin Liu, Sara Sunshine, James Peng, Douglas Black, Anthea M Mitchell, Sabrina A Mann, Genay Pilarowski, Kelsey C Zorn, Luis Rubio, Sara Bravo, Carina Marquez, Joseph J Sabatino, Kristen Mittl, Maya Petersen, Diane Havlir, and Joseph DeRisi
- Subjects
Antibodies, Viral ,Medical and Health Sciences ,Neutralization ,2.1 Biological and endogenous factors ,Immunology and Allergy ,Viral ,Aetiology ,Neutralizing antibody ,Neutralizing ,Lung ,B.1.617.2 ,biology ,Brief Report ,Biological Sciences ,natural infection ,Phenotype ,Spike Glycoprotein ,Vaccination ,AcademicSubjects/MED00290 ,Infectious Diseases ,Spike Glycoprotein, Coronavirus ,Pneumonia & Influenza ,antibody escape ,Spike (software development) ,Antibody ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,B.1.1.529 ,B.1.1.529 (Omicron) ,immune exposure ,Microbiology ,Antibodies ,Article ,Vaccine Related ,Immune system ,Biodefense ,Humans ,SARS-CoV-2 ,Prevention ,COVID-19 ,Pneumonia ,neutralization ,vaccination ,B.1.617.2 (Delta) ,Antibodies, Neutralizing ,Coronavirus ,Emerging Infectious Diseases ,Good Health and Well Being ,variant ,Antibody Formation ,Immunology ,biology.protein ,Immunization - Abstract
The wide spectrum of SARS-CoV-2 variants with phenotypes impacting transmission and antibody sensitivity necessitates investigation of the immune response to different spike protein versions. Here, we compare the neutralization of variants of concern, including B.1.617.2 (Delta) and B.1.1.529 (Omicron) in sera from individuals exposed to variant infection, vaccination, or both. We demonstrate that neutralizing antibody responses are strongest against variants sharing certain spike mutations with the immunizing exposure. We also observe that exposure to multiple spike variants increases the breadth of variant cross-neutralization. These findings contribute to understanding relationships between exposures and antibody responses and may inform booster vaccination strategies., SUMMARY This study characterizes neutralization of eight different SARS-CoV-2 variants, including Delta and Omicron, with respect to nine different prior exposures, including vaccination, booster, and infections with Delta, Epsilon, and others. Different exposures were found to confer substantially differing neutralization specificity.
- Published
- 2021
- Full Text
- View/download PDF
36. SOX transcription factors direct TCF-independent WNT/beta-catenin transcription
- Author
-
Leslie Brown, Aaron M. Zorn, Shreyasi Mukherjee, and David M. Luedeke
- Subjects
SOX Transcription Factors ,SOX2 ,Transcription (biology) ,embryonic structures ,Wnt signaling pathway ,Biology ,Induced pluripotent stem cell ,Enhancer ,Beta (finance) ,Chromatin ,Cell biology - Abstract
WNT/ß-catenin signaling regulates gene expression across numerous biological contexts including development, stem cell homeostasis and tissue regeneration, and dysregulation of this pathway has been implicated in many diseases including cancer. One fundamental question is how distinct WNT target genes are activated in a context-specific manner, given the dogma that most, if not all, WNT/ß-catenin responsive transcription is mediated by TCF/LEF transcription factors (TFs) that have similar DNA-binding specificities. Here we show that the SOX family of TFs direct lineage-specific WNT/ß-catenin responsive transcription during the differentiation of human pluripotent stem cells (hPSCs) into definitive endoderm (DE) and neuromesodermal progenitors (NMPs). Using time-resolved multi-omics analyses, we show that ß-catenin association with chromatin is highly dynamic, colocalizing with distinct TCFs and/or SOX TFs at distinct stages of differentiation, indicating both cooperative and competitive modes of genomic interactions. We demonstrate that SOX17 and SOX2 are required to recruit ß-catenin to hundreds of lineage-specific WNT-responsive enhancers, many of which are not occupied by TCFs. At a subset of these TCF-independent enhancers, SOX TFs are required to both establish a permissive chromatin landscape and recruit a WNT-enhanceosome complex that includes ß-catenin, BCL9, PYGO and transcriptional coactivators to direct SOX/ß-catenin-dependent transcription. Given that SOX TFs are expressed in almost every cell type, these results have broad mechanistic implications for the specificity of WNT responses across many developmental and disease contexts.
- Published
- 2021
- Full Text
- View/download PDF
37. Conjugation Inhibitors Effectively Prevent Plasmid Transmission in Natural Environments
- Author
-
Raul Fernandez-Lopez, Gabriel Moyano, Carolina Palencia-Gándara, Bruno Gonzalez-Zorn, María Getino, Fernando de la Cruz, Santiago Redondo, Universidad de Cantabria, and European Commission
- Subjects
Microcosm ,antibiotic resistance ,Mouse ,Antibiotic resistance ,Observation ,medicine.disease_cause ,Mice ,Plasmid ,Gut ,conjugation inhibitor ,Conjugation inhibitor ,Zebrafish ,0303 health sciences ,biology ,Chemistry ,Bacterial conjugation ,Gene Transfer Techniques ,QR1-502 ,3. Good health ,Anti-Bacterial Agents ,Alkynes ,Horizontal gene transfer ,Fatty Acids, Unsaturated ,gut ,Plasmids ,conjugation ,plasmids ,Gene Transfer, Horizontal ,Microbiology ,03 medical and health sciences ,Rivers ,Virology ,medicine ,Escherichia coli ,Animals ,Gene ,mouse ,030304 developmental biology ,Bacteria ,030306 microbiology ,Conjugation ,Pathogenic bacteria ,biology.organism_classification ,zebrafish ,Animal Feed ,Gastrointestinal Microbiome ,microcosm ,Mice, Inbred C57BL ,bacterial conjugation - Abstract
© 2021 Palencia-Gándara et al., Plasmid conjugation is a major route for the spread of antibiotic resistance genes. Inhibiting conjugation has been proposed as a feasible strategy to stop or delay the propagation of antibiotic resistance genes. Several compounds have been shown to be conjugation inhibitors in vitro, specifically targeting the plasmid horizontal transfer machinery. However, the in vivo efficiency and the applicability of these compounds to clinical and environmental settings remained untested. Here we show that the synthetic fatty acid 2-hexadecynoic acid (2-HDA), when used as a fish food supplement, lowers the conjugation frequency of model plasmids up to 10-fold in controlled water microcosms. When added to the food for mice, 2-HDA diminished the conjugation efficiency 50-fold in controlled plasmid transfer assays carried out in the mouse gut. These results demonstrate the in vivo efficiency of conjugation inhibitors, paving the way for their potential application in clinical and environmental settings., The work performed by the de la Cruz research group was supported by the European Union Seventh Framework Program (FP7-HEALTH-2011-single-stage) “Evolution and Transfer of Antibiotic Resistance” (EvoTAR), grant agreement number 282004. The work performed by C.P.-G. and M.G. was supported by Ph.D. fellowships funded by the University of Cantabria. The work performed by the B.G.-Z. laboratory was supported by The EFFORT project (www.effort-against-amr.eu) FP7-KBBE-2013-7, grant agreement 613754.
- Published
- 2021
38. Assigning Defined Daily/Course Doses for Antimicrobials in Turkeys to Enable a Cross-Country Quantification and Comparison of Antimicrobial Use
- Author
-
Joosten, Philip, Sarrazin, Steven, Chauvin, Claire, Moyano, Gabriel, Wadepohl, Katharina, Gompel, Liese Van, Wagenaar, Jaap A., Dewulf, Jeroen, Battisti, A., Caprioli, A., Aarestrup, F., Hald, T., Duarte, S., Wasyl, D., Krasucka, D., Biernacki, B., Szumilo, J., Daskalov, H., Saatkamp, H., Stärk, K., Sanders, P., David, J., Gonzalez-Zorn, B., Blaha, T., Brandt, M., Graveland, H., Schmitt, H., Luiken, R.E.C., Heederik, D.J.J., Mevius, D., van Essen, A., dIRAS RA-I&I I&I, Klinische infectiologie en microb. lab., and dI&I I&I-4
- Subjects
Florfenicol ,Veterinary medicine ,PHARMACOKINETICS ,Epidemiology ,WASS ,Antimicrobial resistance ,Biochemistry ,0403 veterinary science ,Pharmacology, Toxicology and Pharmaceutics(all) ,chemistry.chemical_compound ,turkeys ,Pharmacology (medical) ,General Pharmacology, Toxicology and Pharmaceutics ,FLORFENICOL ,Avicultura ,2. Zero hunger ,0303 health sciences ,Incidence (epidemiology) ,Bacteriologie ,04 agricultural and veterinary sciences ,Bacteriology, Host Pathogen Interaction & Diagnostics ,Antimicrobial ,Antimicrobial quantification ,3. Good health ,Antimicrobial use ,Infectious Diseases ,Microbiology (medical) ,Turkeys ,Farmacología veterinaria ,Bioinformatica & Diermodellen ,040301 veterinary sciences ,Bedrijfseconomie ,RM1-950 ,Biology ,Microbiology ,treatment incidence ,Article ,03 medical and health sciences ,Antibiotic resistance ,Business Economics ,Bio-informatics & Animal models ,Epidemiology, Bio-informatics & Animal models ,Veterinary Sciences ,antimicrobial resistance ,Pharmacology ,Host Pathogen Interaction & Diagnostics ,Epidemiologie ,Treatment incidence ,030306 microbiology ,Broiler ,Bacteriology ,antimicrobial use ,Host Pathogen Interactie & Diagnostiek ,quantification ,Toxicology and Pharmaceutics(all) ,Defined daily dose ,chemistry ,Epidemiologie, Bioinformatica & Diermodellen ,Bacteriologie, Host Pathogen Interactie & Diagnostiek ,antimicrobial ,POULTRY ,Therapeutics. Pharmacology ,Flock ,RESISTANCE - Abstract
Antimicrobial resistance (AMR) threatens our public health and is mainly driven by antimicrobial usage (AMU). For this reason the World Health Organization calls for detailed monitoring of AMU over all animal sectors involved. Therefore, we aimed to quantify AMU on turkey farms. First, turkey-specific Defined Daily Dose (DDDturkey) was determined. These were compared to the broiler alternative from the European Surveillance of Veterinary Antimicrobial Consumption (DDDvet), that mention DDDvet as a proxy for other poultry species. DDDturkey ranged from being 81.5% smaller to 48.5% larger compared to its DDDvet alternative for broilers. Second, antimicrobial treatments were registered on 60 turkey farms divided over France, Germany and Spain between 2014 and 2016 (20 flocks per country). Afterwards, AMU was quantified using treatment incidence (TI) per 100 days. TI expresses the percentage of the rearing period that the turkeys were treated with a standard dose of antimicrobials. Minimum, median and maximum TI at flock level and based on DDDturkey = 0.0, 10.0 and 65.7, respectively. Yet, a huge variation in amounts of antimicrobials used at flock level was observed, both within and between countries. Seven farms (12%) did not use any antimicrobials. Aminopenicillins, polymyxins, and fluoroquinolones were responsible for 72.2% of total AMU. The proportion of treating farms peaked on week five of the production cycle (41.7%), and 79.4% of the total AMU was administered in the first half of production. To conclude, not all DDDvet values for broilers can be applied to turkeys. Additionally, the results of AMU show potential for reducing and improving AMU on turkey farms, especially concerning the usage of critically important antimicrobials.
- Published
- 2021
39. Biotechnologische Produktion von Fleischaromen in Submerskulturen von Laetiporus sp
- Author
-
Holger Zorn, S. Yalman, T. Trapp, and Marco A. Fraatz
- Subjects
Biology - Published
- 2021
- Full Text
- View/download PDF
40. The agronomic and economic viability of innovative cropping systems to reduce Fusarium head blight and related mycotoxins in wheat
- Author
-
Dimitrios Drakopoulos, Hans-Rudolf Forrer, Alexander Zorn, Thomas D. Bucheli, Felix E. Wettstein, Johan Six, Susanne Vogelgsang, and Andreas Kägi
- Subjects
Crop residue ,business.product_category ,010504 meteorology & atmospheric sciences ,Biology ,01 natural sciences ,Crop ,Plough ,Cropping system ,Cover crop ,0105 earth and related environmental sciences ,2. Zero hunger ,Crop yield ,fungi ,food and beverages ,04 agricultural and veterinary sciences ,15. Life on land ,biology.organism_classification ,Tillage ,Agronomy ,040103 agronomy & agriculture ,0401 agriculture, forestry, and fisheries ,Animal Science and Zoology ,business ,Agronomy and Crop Science ,White mustard ,Fusarium head blight ,Wheat ,Mycotoxin ,Food safety ,Intercrop - Abstract
CONTEXT The effective control of Fusarium head blight (FHB) in wheat, mainly caused by the toxigenic fungus Fusarium graminearum, has a significant impact on food safety worldwide. As maize is one of the main hosts of F. graminearum, the risk of infection by this plant pathogen is highest when wheat is grown after maize and infected crop residues are not buried through ploughing. OBJECTIVES This study aimed to investigate the agronomic and economic viability of two innovative cropping systems with the goal to reduce the risk of FHB and mycotoxins in subsequent wheat. These systems were maize-intercropping and cover cropping with different plant species before the wheat growing season under reduced tillage practices. METHODS For the maize-intercropping study, red clover, sudangrass, phacelia, white mustard and Indian mustard were used as intercrops with grain maize and compared with a sole maize crop in a grain maize-winter wheat rotation under no-tillage or reduced tillage. For the cover cropping study, white mustard, Indian mustard and winter pea were used as interval cover crops in a silage maize-spring wheat rotation under no-tillage and compared with treatments without a cover crop, i.e. herbicide or plough applied after silage maize. The incidence of Fusarium head blight causing species and the accumulation of mycotoxins in grains of wheat as well as the crop yield were monitored. In addition, an economic assessment was conducted by calculating the receipts, operating costs and gross margin for each cropping system. RESULTS AND CONCLUSIONS Growing intercrops with maize or interval cover crops in a maize-wheat rotation under reduced tillage decreased mycotoxins in wheat while maintaining wheat yield. The use of white mustard or Indian mustard as intercrops reduced deoxynivalenol in winter wheat by up to 52% compared with maize grown as a sole crop. The use of white mustard, Indian mustard or winter pea as interval cover crops also reduced deoxynivalenol and improved yield in spring wheat by up to 85% and 25%, respectively. Remarkably, the toxin reduction through these cover crops was comparable with that obtained by ploughing. However, due to increased operating costs, we observed economic trade-offs in these innovative cropping systems, i.e. 7–25% reduced gross margin over the entire rotation. SIGNIFICANCE Both cereal growers and consumers can benefit from the recommended practices, which considerably lower the risk of mycotoxin contamination in harvest products while maintaining crop yield. To address the economic trade-offs, policy makers should support innovation in cropping systems, enhancing food safety while also ensuring the economic viability of cereal production systems.
- Published
- 2021
41. Safety evaluation of the food enzyme catalase from the genetically modified Aspergillus niger strain DP‐Azw58
- Author
-
EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP), Claude Lambré, José Manuel Barat Baviera, Claudia Bolognesi, Pier Sandro Cocconcelli, Riccardo Crebelli, David Michael Gott, Konrad Grob, Evgenia Lampi, Marcel Mengelers, Alicja Mortensen, Gilles Rivière, Inger‐Lise Steffensen, Christina Tlustos, Henk van Loveren, Laurence Vernis, Holger Zorn, Boet Glandorf, Lieve Herman, Ana Gomes, Yi Liu, Joaquim Maia, Sandra Rainieri, and Andrew Chesson
- Subjects
No-observed-adverse-effect level ,TECNOLOGIA DE ALIMENTOS ,hydrogen-peroxide oxidoreductase [Hydrogen-peroxide] ,Veterinary (miscellaneous) ,TP1-1185 ,Plant Science ,medicine.disease_cause ,Microbiology ,Oxidoreductase ,medicine ,Food enzyme ,TX341-641 ,hydrogen‐peroxide:hydrogen‐peroxide oxidoreductase ,genetically modified microorganism ,Food science ,Food8822 ,EC 1.11.1.6 ,chemistry.chemical_classification ,Genetically modified microorganism ,Strain (chemistry) ,biology ,Nutrition. Foods and food supply ,Chemical technology ,catalase ,Aspergillus niger ,Catalase ,biology.organism_classification ,food enzyme ,Genetically modified organism ,Hydrogen-peroxide:hydrogen-peroxide oxidoreductase ,Scientific Opinion ,Enzyme ,chemistry ,biology.protein ,Animal Science and Zoology ,Parasitology ,Genotoxicity ,Food Science - Abstract
[EN] The food enzyme catalase (hydrogen-peroxide:hydrogen-peroxide oxidoreductase; EC 1.11.1.6) is produced with the genetically modified Aspergillus niger strain DP-Azw58 by Danisco US, Inc. The genetic modifications do not give rise to safety concerns. The food enzyme is considered free from viable cells of the production organism and its DNA. It is intended to be used in egg processing. Based on the maximum use levels, dietary exposure to the food enzyme-total organic solids (TOS) was estimated to be up to 1 mu g TOS/kg body weight (bw) per day in European populations. Genotoxicity tests did not indicate a safety concern. The systemic toxicity was assessed by means of a repeated dose 90-day oral toxicity study in rats. The Panel identified a no observed adverse effect level of 1,288 mg TOS/kg bw per day, the highest dose tested, which when compared with the estimated dietary exposure, results in a margin of exposure of at least 1.3 x 10(6). A search for similarity of the amino acid sequence of the food enzyme to known allergens was made and one match was found. The Panel considered that, under the intended conditions of use, the risk of allergic sensitisation and elicitation reactions by dietary exposure cannot be excluded, but the likelihood for this to occur is considered to be low. Based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns under the intended conditions of use. (C) 2021 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.
- Published
- 2021
- Full Text
- View/download PDF
42. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
- Author
-
Ana Peixoto, Ian Tomlinson, Thérèse Truong, Amanda E. Toland, Anna Marie Mulligan, Michael Untch, Susan J. Ramus, Kenneth Offit, John J. Spinelli, Clarice R. Weinberg, Kyriaki Michailidou, Javier Benitez, Rita K. Schmutzler, Lizet E. van der Kolk, Heli Nevanlinna, Annika Lindblom, Sara Margolin, Stella Koutros, Elza Khusnutdinova, Diana Eccles, Lenka Foretova, Wolfgang Janni, Jennifer T. Loud, Roger L. Milne, Patrick Neven, Thomas U. Ahearn, Hedy S. Rennert, Karolina Prajzendanc, Melissa C. Southey, Ramunas Janavicius, Finn Cilius Nielsen, Pascal Guénel, Antoinette Hollestelle, Jolanta Lissowska, Ni Zhao, Melissa Christiaens, Hoda Anton-Culver, Ans M.W. van den Ouweland, Christopher A. Haiman, Debra Frost, Vessela N. Kristensen, Bernard Peissel, Muhammad Usman Rashid, Noura Mebirouk, Claudine Isaacs, Matthias W. Beckmann, Sofia Khan, Xia Jiang, Jack A. Taylor, Peter Hillemanns, Robert Winqvist, Susan L. Neuhausen, Marina Bermisheva, Alicja Wolk, Katherine L. Nathanson, Judy Garber, Siranoush Manoukian, Simon S. Cross, Flavio Lejbkowicz, Manjeet K. Bolla, Goska Leslie, Saundra S. Buys, Banu Arun, Xiaohong R. Yang, Peter Schürmann, Irene Konstantopoulou, Mia M. Gaudet, Rob A. E. M. Tollenaar, Joe Dennis, Louise Izatt, David E. Goldgar, Anna Jakubowska, Alicja Lukomska, Fabienne Lesueur, Susanna C. Larsson, Peter Devilee, Helen Byers, Bernd Holleczek, Marc Tischkowitz, Arif B. Ekici, Austin Miller, Carl Blomqvist, Christopher R. Hake, Paul D.P. Pharoah, Harvey A. Risch, Kristin K. Zorn, Mehdi Manoochehri, Kamila Czene, Peter A. Fasching, Trinidad Caldés, Hanna Huebner, Agnes Jager, William G. Newman, Lesley McGuffog, Maren T. Scheuner, Nick Orr, Susan M. Domchek, Antonis C. Antoniou, Peter Kraft, Pooja Middha Kapoor, Daniel R. Barnes, Christine L. Clarke, Douglas F. Easton, Bernadette A M Heemskerk-Gerritsen, Ross L. Prentice, Mark E. Sherman, Elizabeth J. van Rensburg, Michael Jones, Åke Borg, Diether Lambrechts, Mark H. Greene, Mark S. Goldberg, Peter J. Hulick, Maria Elena Martinez, Arto Mannermaa, Frans B. L. Hogervorst, Christian F. Singer, Johanna Rantala, Esther M. John, Jesse Nodora, Wendy K. Chung, Csilla Szabo, Mads Thomassen, Tracy A. O'Mara, Kelly-Anne Phillips, Manuela Gago-Dominguez, Jacques Simard, John L. Hopper, Jacopo Azzollini, Rudolf Kaaks, Haoyu Zhang, Eitan Friedman, Heiko Becher, János Papp, Thomas Rüdiger, Alison M. Dunning, Daniele Campa, Alfons Meindl, Lothar Häberle, Ana Blanco, Eric Hahnen, Barbara Wappenschmidt, Elaine F. Harkness, Audrey Y. Jung, Guanghao Qi, Zumuruda Abu Ful, Maria A. Caligo, Priyanka Sharma, Håkan Olsson, Elke M van Veen, Marion Piedmonte, Linetta B. Koppert, Usha Menon, Laura Matricardi, Jonine D. Figueroa, Wei Zheng, Milena Jakimovska, Katarzyna Białkowska, Renske Keeman, Matti A. Rookus, William J. Tapper, J. Peto, Paul L. Auer, Andreas Schneeweiss, Xiao-Ou Shu, Miriam Dwek, Elvira Mingazheva, Hermann Brenner, Emilija Lazarova, Atocha Romero, Rulla M. Tamimi, Laura Papi, Hans Wildiers, Catriona McLean, Montserrat Garcia-Closas, Matthias Rübner, Thomas Brüning, Graham G. Giles, Robert J. MacInnis, Hans Christiansen, Sten Cornelissen, Paul A. James, Georgia Chenevix-Trench, Tjoung-Won Park-Simon, Nilanjan Chatterjee, D. Gareth Evans, Ignacio Briceño, Mary B. Daly, Annegien Broeks, Evgeny N. Imyanitov, Jonathan Beesley, Snezhana Smichkoska, Thilo Dörk, Yon-Dschun Ko, Paolo Peterlongo, Celine M. Vachon, Claire Mulot, Kristiina Aittomäki, Liene Nikitina-Zake, Manuel R. Teixeira, Edith Olah, Florentia Fostira, Beth N. Peshkin, Pierre Laurent-Puig, M. B. Terry, Michael T. Parsons, Anna González-Neira, Julie Lecarpentier, Jacek Gronwald, Fergus J. Couch, Mariarosaria Calvello, Leigha Senter, Ute Hamann, Brigitte Rack, Marco Montagna, Simon A. Gayther, Barbara Burwinkel, Anne-Vibeke Lænkholm, Irene L. Andrulis, Sabine Behrens, Beth Y. Karlan, Anthony J. Swerdlow, Marjanka K. Schmidt, Cari M. Kitahara, Emmanouil Saloustros, Dijana Plaseska-Karanfilska, Melissa A. Troester, Diana Torres, Daniel Barrowdale, Elinor J. Sawyer, Hiltrud Brauch, Minouk J. Schoemaker, Dale P. Sandler, José A. García-Sáenz, Jennifer Stone, Qin Wang, Conxi Lázaro, Paolo Radice, Jan Lubinski, Jose E. Castelao, Natalia Bogdanova, Drakoulis Yannoukakos, Davide Bondavalli, Kristan J. Aronson, Gad Rennert, Wing-Yee Lo, Robert N. Hoover, Dominique Stoppa-Lyonnet, Nadine Tung, Stephen J. Chanock, Andrew K. Godwin, Angela Cox, Maartje J. Hooning, Anthony Howell, Volker Arndt, Penny Soucy, Jenny Chang-Claude, Kathleen Claes, Olufunmilayo I. Olopade, Jeffrey N. Weitzel, Stig E. Bojesen, Sara Y Brucker, Darcy L. Thull, Darya Prokofyeva, Taru A. Muranen, Ben Schöttker, Orland Diez, Susan M. Gapstur, Sarah Sampson, Bernardo Bonanni, Per Hall, Ana Vega, Medical Oncology, Surgery, and Clinical Genetics
- Subjects
Oncology ,medicine.medical_specialty ,Linkage disequilibrium ,Carcinogenesis ,Estrogen receptor ,Genome-wide association study ,Breast Neoplasms ,Triple Negative Breast Neoplasms ,Biology ,Gene mutation ,Linkage Disequilibrium ,Càncer de mama ,03 medical and health sciences ,0302 clinical medicine ,Breast cancer ,SDG 3 - Good Health and Well-being ,Internal medicine ,Genetics ,Genetic predisposition ,medicine ,Humans ,Genetic Predisposition to Disease ,Carcinogènesi ,Triple-negative breast cancer ,030304 developmental biology ,Medicinsk genetik ,0303 health sciences ,Genetic heterogeneity ,BRCA1 Protein ,medicine.disease ,3. Good health ,Case-Control Studies ,Female ,Mutation ,Genome-Wide Association Study ,Medical Genetics ,030217 neurology & neurosurgery - Abstract
Genome-wide analysis identifies 32 loci associated with breast cancer susceptibility, accounting for estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status and tumor grade. Breast cancer susceptibility variants frequently show heterogeneity in associations by tumor subtype(1-3). To identify novel loci, we performed a genome-wide association study including 133,384 breast cancer cases and 113,789 controls, plus 18,908 BRCA1 mutation carriers (9,414 with breast cancer) of European ancestry, using both standard and novel methodologies that account for underlying tumor heterogeneity by estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status and tumor grade. We identified 32 novel susceptibility loci (P < 5.0 x 10(-8)), 15 of which showed evidence for associations with at least one tumor feature (false discovery rate < 0.05). Five loci showed associations (P < 0.05) in opposite directions between luminal and non-luminal subtypes. In silico analyses showed that these five loci contained cell-specific enhancers that differed between normal luminal and basal mammary cells. The genetic correlations between five intrinsic-like subtypes ranged from 0.35 to 0.80. The proportion of genome-wide chip heritability explained by all known susceptibility loci was 54.2% for luminal A-like disease and 37.6% for triple-negative disease. The odds ratios of polygenic risk scores, which included 330 variants, for the highest 1% of quantiles compared with middle quantiles were 5.63 and 3.02 for luminal A-like and triple-negative disease, respectively. These findings provide an improved understanding of genetic predisposition to breast cancer subtypes and will inform the development of subtype-specific polygenic risk scores.
- Published
- 2020
- Full Text
- View/download PDF
43. GIRK1 triggers multiple cancer-related pathways in the benign mammary epithelial cell line MCF10A
- Author
-
Wolfgang Schreibmayer, Ruth Prassl, Stefanie Stanzer, Katja Ester, Sonja Langthaler, Nassim Ghaffari-Tabrizi-Wizsy, Simin Rezania, Andreas Prokesch, Helmut Ahammer, Dieter Platzer, Susanne Scheruebel, Brigitte Pelzmann, Klaus Zorn-Pauly, Gebhard Schratter, Trevor DeVaney, Thomas Bauernhofer, Kurt Schmidt, Astrid Gorischek, and Stephan W Jahn
- Subjects
Cell biology ,Carcinogenesis ,Molecular biology ,Biophysics ,lcsh:Medicine ,Breast Neoplasms ,Diseases ,Biology ,Biochemistry ,Article ,GIRK1 ,breast cancer ,MCF10A ,MCF7 ,Transcriptome ,Extracellular matrix ,03 medical and health sciences ,0302 clinical medicine ,Breast cancer ,Medical research ,Cell Movement ,Neoplasms ,medicine ,Humans ,Mammary Glands, Human ,skin and connective tissue diseases ,lcsh:Science ,030304 developmental biology ,Cancer ,Regulation of gene expression ,0303 health sciences ,Multidisciplinary ,Molecular medicine ,lcsh:R ,Cell migration ,medicine.disease ,3. Good health ,Gene Expression Regulation, Neoplastic ,G Protein-Coupled Inwardly-Rectifying Potassium Channels ,Oncology ,030220 oncology & carcinogenesis ,Lymphatic Metastasis ,Cancer research ,MCF-7 Cells ,Female ,lcsh:Q ,Wound healing ,Biomarkers - Abstract
Excessive expression of subunit 1 of GIRK1 in ER+ breast tumors is associated with reduced survival times and increased lymph node metastasis in patients. To investigate possible tumor-initiating properties, benign MCF10A and malign MCF7 mammary epithelial cells were engineered to overexpress GIRK1 neoplasia associated vital parameters and resting potentials were measured and compared to controls. The presence of GIRK1 resulted in resting potentials negative to the controls. Upon GIRK1 overexpression, several cellular pathways were regulated towards pro-tumorigenic action as revealed by comparison of transcriptomes of MCF10AGIRK1 with the control (MCF10AeGFP). According to transcriptome analysis, cellular migration was promoted while wound healing and extracellular matrix interactions were impaired. Vital parameters in MCF7 cells were affected akin the benign MCF10A lines, but to a lesser extent. Thus, GIRK1 regulated cellular pathways in mammary epithelial cells are likely to contribute to the development and progression of breast cancer.
- Published
- 2019
- Full Text
- View/download PDF
44. Pan-viral serology implicates enteroviruses in acute flaccid myelitis
- Author
-
M. Steven Oberste, Kevin Messacar, Joseph L. DeRisi, Ariane Soldatos, Charles Y. Chiu, Bethany L. Johnson-Kerner, Victoria Chu, Emily D. Crawford, Riley Bove, Kendall B. Nash, Hugh J. McMillan, Leslie Benson, Isobel A. Hawes, Michelle Tan, Joy Z. Ding, Wesley Wu, Lillian M. Khan, Amy Lyden, Jennifer L. Konopka-Anstadt, Cristina M. Tato, Rachel L. Marine, Gavin A. Sowa, Benjamin Briggs, Tanuja Chitnis, Debra A. Wadford, Terry Fei Fan Ng, Carol A. Glaser, John E. Pak, Kelsey C. Zorn, Amy A. Gelfand, Carly K. Cheung, Stephen L. Hauser, Hannah A. Sample, Prashanth S. Ramachandran, Brian D. O’Donovan, Michael R. Wilson, Samuel R. Dominguez, Ryan D. Schubert, Adriana S. Lopez, Akshaya Ramesh, Debarko Banerji, Cynthia Yen, Rene Sit, Mark P. Gorman, Kalpathy S. Krishnamoorthy, and W. Allan Nix
- Subjects
Male ,0301 basic medicine ,Antibodies, Viral ,medicine.disease_cause ,Medical and Health Sciences ,Serology ,0302 clinical medicine ,Cerebrospinal fluid ,Seroepidemiologic Studies ,2.1 Biological and endogenous factors ,Viral ,Aetiology ,Child ,Antigens, Viral ,Enterovirus ,Pediatric ,biology ,Neuromuscular Diseases ,General Medicine ,Myelitis ,Child, Preschool ,030220 oncology & carcinogenesis ,Female ,Antibody ,Viral load ,Immunology ,Article ,Antibodies ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,Rare Diseases ,Antigen ,Enterovirus Infections ,medicine ,Humans ,Antigens ,Preschool ,business.industry ,Prevention ,Neurosciences ,Infant ,RNA ,Virology ,United States ,Acute flaccid myelitis ,Good Health and Well Being ,030104 developmental biology ,Central Nervous System Viral Diseases ,biology.protein ,business - Abstract
Since 2012, the United States of America has experienced a biennial spike in pediatric acute flaccid myelitis (AFM)1-6. Epidemiologic evidence suggests non-polio enteroviruses (EVs) are a potential etiology, yet EV RNA is rarely detected in cerebrospinal fluid (CSF)2. CSF from children with AFM (n = 42) and other pediatric neurologic disease controls (n = 58) were investigated for intrathecal antiviral antibodies, using a phage display library expressing 481,966 overlapping peptides derived from all known vertebrate and arboviruses (VirScan). Metagenomic next-generation sequencing (mNGS) of AFM CSF RNA (n = 20 cases) was also performed, both unbiased sequencing and with targeted enrichment for EVs. Using VirScan, the viral family significantly enriched by the CSF of AFM cases relative to controls was Picornaviridae, with the most enriched Picornaviridae peptides belonging to the genus Enterovirus (n = 29/42 cases versus 4/58 controls). EV VP1 ELISA confirmed this finding (n = 22/26 cases versus 7/50 controls). mNGS did not detect additional EV RNA. Despite rare detection of EV RNA, pan-viral serology frequently identified high levels of CSF EV-specific antibodies in AFM compared with controls, providing further evidence for a causal role of non-polio EVs in AFM.
- Published
- 2019
- Full Text
- View/download PDF
45. Enrichment of Erucic and Gondoic Fatty Acids fromCrambeandCamelinaOils Catalyzed byGeotrichum candidumLipases I and II
- Author
-
Uwe T. Bornscheuer, Isabel Oroz-Guinea, and Katja Zorn
- Subjects
Gondoic acid ,030309 nutrition & dietetics ,General Chemical Engineering ,Gondoic Acid ,Camelina oil ,7. Clean energy ,03 medical and health sciences ,chemistry.chemical_compound ,Hydrolysis ,0404 agricultural biotechnology ,Crambe ,Crambe oil ,Food science ,Lipase ,chemistry.chemical_classification ,Geotrichum candidum lipase ,0303 health sciences ,biology ,Organic Chemistry ,Erucic acid ,Fatty acid ,Fatty acid enrichment ,04 agricultural and veterinary sciences ,Oleochemical ,biology.organism_classification ,040401 food science ,Camelina ,chemistry ,biology.protein - Abstract
Erucic (22:1, cisΔ13) and gondoic acids (20:1, cisΔ11) are building blocks obtained from renewable sources for the oleochemical industry. Different biocatalytic strategies for the enrichment of these compounds with high recovery yields were developed in our group. Geotrichum candidum lipases (GCL) strongly discriminate against fatty acids longer than 18 carbon atoms. Thus, GCL‐I and ‐II were investigated using hydrolysis or ethanolysis reactions with Crambe and Camelina oils. Hydrolysis was also studied using fatty acid ethyl esters (FAEE) derived from the corresponding oil. Both isoforms were highly selective; however, interesting differences were observed. Although it has been reported that GCL‐I displays a higher preference toward 18 cisΔ9, which is present in the studied oils at high levels, GCL‐II showed higher enrichment values during hydrolysis independent of the substrate used. Hence, enrichments of 87% (Crambe oil) and 82% (Crambe FAEE) for erucic acid and 50% (Camelina oil) and 45% (Camelina FAEE) for gondoic acid, with recovery values between 89% and 99%, were achieved. On the contrary, the best enzyme for ethanolysis was GCL‐I (82% and 41% for erucic and gondoic acid, respectively). In this case, although GCL‐II also displayed good enrichment and recovery levels (77% and 28%, respectively), they were lower compared to the former reactions. In both ethanolysis reactions, the FAEE fraction contained between 92% and 97% of 18 unsaturated fatty acids.
- Published
- 2019
- Full Text
- View/download PDF
46. Description of Callistethus hamus sp. nov. (Coleoptera, Scarabaeidae, Rutelinae) from continental Southeast Asia using synchrotron to illustrate the aedeagus
- Author
-
Carsten Zorn, Yuanyuan Lu, Ming Bai, and David Král
- Subjects
0106 biological sciences ,China ,Insecta ,Arthropoda ,010607 zoology ,Synchrotron radiation ,3d model ,Scarabaeidae ,010603 evolutionary biology ,01 natural sciences ,Rutelinae ,law.invention ,Southeast asia ,Paleontology ,law ,lcsh:Zoology ,Anomalini ,Animalia ,Scarabaeoidea ,lcsh:QL1-991 ,Ecology, Evolution, Behavior and Systematics ,new species ,biology ,Callistethus ,3D models ,biology.organism_classification ,Synchrotron ,Coleoptera ,Aedeagus ,Geography ,Vietnam ,Laos ,Rutelidae ,Animal Science and Zoology - Abstract
A new species, Callistethus hamus Lu & Zorn, sp. nov., is described from China, Laos, and Vietnam. Additionally, we used synchrotron (Shanghai Synchrotron Radiation Facility) to scan the aedeagus. The virtual 3D model of the aedeagus is reconstructed and provided.
- Published
- 2019
- Full Text
- View/download PDF
47. Is There a Role for Natural Antibodies in Rejection Following Transplantation?
- Author
-
Emmanuel Zorn and Sarah B. See
- Subjects
Graft Rejection ,medicine.medical_specialty ,medicine.medical_treatment ,Autoimmunity ,Context (language use) ,Disease ,030230 surgery ,medicine.disease_cause ,Antibodies ,Article ,Organ transplantation ,03 medical and health sciences ,0302 clinical medicine ,Antigen ,HLA Antigens ,Humans ,Medicine ,Lung transplantation ,Transplantation ,biology ,business.industry ,Graft Survival ,Organ Transplantation ,Immunology ,biology.protein ,030211 gastroenterology & hepatology ,Antibody ,business - Abstract
Antibody-mediated rejection continues to hinder long-term survival of solid organ allografts. Natural antibodies (Nabs) with polyreactive and autoreactive properties have recently emerged as potential contributors to antibody-mediated graft rejection. This review discusses Nabs, their functions in health and disease, their significance in rejection following kidney, heart, and lung transplantation, and their implication in serum reactivity to key antigens associated with rejection. Finally, potential effector mechanisms of Nabs in the context of transplantation are explored.
- Published
- 2019
- Full Text
- View/download PDF
48. Production, characterization, and in vivo half-life extension of polymeric IgA molecules in mice
- Author
-
Victor Yip, Eugene C. Chen, T. Noelle Lombana, Daniel D. Bravo, Sharon Viajar, Sophia Lee, C. Andrew Boswell, Wilson Phung, Marissa L. Matsumoto, Jianyong Wang, Avinash Gill, Christoph Spiess, Farzam Farahi, Julie A. Zorn, Wendy Sandoval, Sharmila Rajan, Alberto Estevez, Danielle Mandikian, and Claudio Ciferri
- Subjects
Glycan ,Glycosylation ,Asialoglycoprotein receptor (ASGPR) ,Recombinant Fusion Proteins ,Immunology ,transcytosis ,Madin Darby Canine Kidney Cells ,N-linked glycan ,03 medical and health sciences ,chemistry.chemical_compound ,serum half-life ,Antibodies, Monoclonal, Murine-Derived ,Mice ,0302 clinical medicine ,polymeric IgG receptor (pIgR) ,Dogs ,In vivo ,Report ,Immunology and Allergy ,Cytotoxic T cell ,Animals ,Humans ,Receptor ,030304 developmental biology ,0303 health sciences ,Mice, Inbred BALB C ,biology ,Immunoglobulin A ,chemistry ,Transcytosis ,Biochemistry ,030220 oncology & carcinogenesis ,Immunoglobulin G ,biology.protein ,Female ,Antibody ,Polymeric immunoglobulin receptor ,Half-Life - Abstract
IgA antibodies have broad potential as a novel therapeutic platform based on their superior receptor-mediated cytotoxic activity, potent neutralization of pathogens, and ability to transcytose across mucosal barriers via polymeric immunoglobulin receptor (pIgR)-mediated transport, compared to traditional IgG-based drugs. However, the transition of IgA into clinical development has been challenged by complex expression and characterization, as well as rapid serum clearance that is thought to be mediated by glycan receptor scavenging of recombinantly produced IgA monomer bearing incompletely sialylated N-linked glycans. Here, we present a comprehensive biochemical, biophysical, and structural characterization of recombinantly produced monomeric, dimeric and polymeric human IgA. We further explore two strategies to overcome the rapid serum clearance of polymeric IgA: removal of all N-linked glycosylation sites creating an aglycosylated polymeric IgA and engineering in FcRn binding with the generation of a polymeric IgG-IgA Fc fusion. While previous reports and the results presented in this study indicate that glycan-mediated clearance plays a major role for monomeric IgA, systemic clearance of polymeric IgA in mice is predominantly controlled by mechanisms other than glycan receptor clearance, such as pIgR-mediated transcytosis. The developed IgA platform now provides the potential to specifically target pIgR expressing tissues, while maintaining low systemic exposure.
- Published
- 2019
49. Insect Meal as Alternative Protein Source Exerts Pronounced Lipid-Lowering Effects in Hyperlipidemic Obese Zucker Rats
- Author
-
Denise K. Gessner, Erika Most, Klaus Eder, Holger Zorn, Anne Schwarz, Gaiping Wen, Robert Ringseis, and Sandra Meyer
- Subjects
medicine.medical_specialty ,Insecta ,Homocysteine ,Protein Array Analysis ,Medicine (miscellaneous) ,Reductase ,Weight Gain ,Random Allocation ,chemistry.chemical_compound ,Internal medicine ,Casein ,medicine ,Animals ,chemistry.chemical_classification ,Meal ,Nutrition and Dietetics ,biology ,Chemistry ,Cholesterol ,Computational Biology ,Fatty acid ,Lipid Metabolism ,medicine.disease ,Animal Feed ,Lipids ,Obesity ,Rats ,Rats, Zucker ,Fatty acid synthase ,Endocrinology ,Gene Expression Regulation ,Liver ,biology.protein ,Dietary Proteins - Abstract
BACKGROUND Specific dietary proteins exert strong health-related effects compared with casein. OBJECTIVE Herein, the hypothesis was tested using screening and conventional biochemical and molecular biological techniques that protein-rich insect meal compared with casein influences metabolic health in hyperlipidemic rats. METHODS A 4-wk feeding trial with male, 8-wk-old homozygous obese Zucker rats (n = 36) and male, 8-wk-old heterozygous lean Zucker rats (n = 12) was performed. Obese rats were randomly divided into 3 obese groups (OC, OI50, and OI100) of 12 rats each and lean rats served as a lean control group (LC). LC and OC were fed a control diet with 20% casein as protein source, whereas in OI50 and OI100 50% and 100% of the casein, respectively, was replaced isonitrogenously by insect meal from Tenebrio molitor L. All data were analyzed by 1-factor ANOVA, except transcriptomic data which were analyzed by groupwise comparisons with the OC group. RESULTS Transcript profiling revealed a coordinated inhibition by -17% to -521% and -37% to -859% of genes involved in fatty acid, triacylglycerol (TG), and cholesterol biosynthesis in the livers of OI100 and OI50, respectively, compared with OC (P
- Published
- 2019
- Full Text
- View/download PDF
50. A Long‐Term Analysis of Channel Morphology and Stream Substrates before and after Sediment Trap Construction in Michigan Trout Streams
- Author
-
Troy G. Zorn, Jan-Michael Hessenauer, and Todd C. Wills
- Subjects
Hydrology ,Morphology (linguistics) ,Ecology ,biology ,Sediment trap (geology) ,STREAMS ,Management, Monitoring, Policy and Law ,Aquatic Science ,biology.organism_classification ,Term (time) ,Trout ,Environmental science ,Ecology, Evolution, Behavior and Systematics ,Communication channel - Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.